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Abstract 
Introduction 
Improved survival rates in the human immunodeficiency virus (HIV) population, due to the use of 
antiretroviral therapy (ART), are associated with increased risk for cardiovascular disease (CVD). 
Although the cardiovascular effects of rooibos as an antioxidant have been well documented its 
nutraceutical properties have yet to be investigated as a possible supplement in ART. 
AIM 
To investigate the cardiovascular effects of Aspalathus linearis/ rooibos infusion supplementation 
during ART, on male Wistar rats and the effects of rooibos tea consumption on the cardiovascular 
profiles of patients on ART. 
Methods 
Male Wistar rats were randomly divided into groups and treated with a fixed dose combination 
(Efavirenz 600mg, emtricitabine 200mg, tenofovir 300mg) and a 2% (w/v) rooibos tea solution 
independently or in combination for 9 weeks. Fluid intake and weights were measured weekly. Hearts 
were perfused on the isolated working heart rig and subjected to 20min global or 35min regional 
ischemia. Functional parameters were recorded and percentage recovery and infarct size (IS) 
calculated. Using the aortic ring protocol for vascular reactivity, thoracic aortas (with and without 
perivascular adipose tissue (PVAT)) were subjected to phenylephrine-induced contraction as well as 
acetylcholine-induced relaxation. Rat serum was collected for biochemical analyses. Participants for 
the human study were recruited and blood samples collected by a phlebotomist. Blood pressure tests 
were conducted, anthropometric data recorded and samples prepared for biochemical analyses. 
Results 
ART increased IS compared to control [Control (% area at risk): 28.17±5.10 , ART: 50.56±4.08] however 
this was not seen in the Rooibos+ART group. In vascular reactivity experiments, without PVAT, ART 
significantly diminished relaxation compared to control (p=0.03) whilst this effect was not observed 
with Rooibos supplementation (p=0.003). Rooibos caused increased contraction compared to control 
(p=0.01), ART (p=0.0457) and the combination (p=0.0468). In the presence of PVAT all treatment 
groups relaxed significantly less than controls (p<0.01). Area under the curve (AUC): Control+PVAT, 
0.00099; Rooibos+PVAT: 0.00079; ART+PVAT, 0.00091; ART+Rooibos+PVAT, 0.00088. Whilst Rooibos 
and ART showed significantly higher contraction than the control (p=0.006 and p=0.03 respectively). 
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AUC: Control+PVAT, 31.45; Rooibos+PVAT: 43.42; ART+PVAT, 36.32; ART+Rooibos+PVAT, 33.34. 
Overall the presence of PVAT caused a significant decrease in contraction compared to the absence 
thereof; Control+PVAT versus Control -PVAT group (p<0.0001); rooibos +PVAT versus rooibos -PVAT 
(p<0.0001), ART+PVAT versus ART -PVAT (p<0.0001) and Rooibos+ART +PVAT versus Rooibos+ART-
PVAT (p<0.0001). Rooibos caused a significant reduction in total cholesterol (TC) levels (p=0.048) 
compared to all other groups. Epidemiological data revealed that drinking rooibos had no significant 
effects on the cardiovascular parameters of patients irrespective of HIV status or ART adherence. 
Discussion and Conclusion 
In aortic rings anti-vasodilatory effects of ART were not observed with rooibos supplementation. ART 
induced significant increase in IS was not observed in the Rooibos + ART treated group. Rooibos 
exerted pro-contractile effects whilst the presence of PVAT reduced contraction of the aortic rings. 
Deleterious effects by the current ART regimen were not observed in the epidemiological study and 
rooibos consumption had no significant effects on the assessed cardiovascular parameters of all 
patient groups. Further scientific investigation is required.  
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Abstrak 
Inleiding 
Antiretrovirale middels (ART) het gelei tot hoër lewensverwagtinge in die menslike 
immuniteitsgebreksvirus (MIV)-populasie, maar ongelukkig ook tot ‘n verhoogde risiko vir 
kardiovaskulêre siektes (KVS).  Alhoewel daar voldoende gepubliseer is oor die anti-oksidant effekte 
van rooibos op die kardiovaskulêre sisteem, is daar ‘n tekort aan inligting oor die potensiaal van 
rooibos as aanvulling tydens ART gebruik. 
Doelwit 
Om in manlike Wistar rotte die kardiovaskulêre effekte van Aspalathus linearis/rooibos as aanvulling 
tydens ART te ondersoek.  Om verder ook die effekte van rooibostee op die kardiovaskulêre profiel 
van pasiënte op ART te ondersoek. 
Metodes 
Rotte was ewekansig verdeel in groepe wat vir 9 weke met ‘n vaste kombinasie dosis (Efavirenz 
600mg, emtricitabine 200mg, tenofovir 300mg) en ‘n 2% (w/v) rooibostee oplossing, alleen of in 
kombinasie, behandel was.  Harte was geperfuseer middle van ‘n geïsoleerde werkhart model, en was 
blootgestel aan 20 min globale-iskemie of 35 min streeks-iskemie.  Funksionele veranderlikes was 
gemeet en die persentasie herstel asook infarktgrootte bereken.  Vaskulêre reaktiwiteit was bepaal 
deur gebruik te maak van aorta ringe, waar die torakale aorta (met of sonder perivaskulêre vet (PVAT)) 
aan fenielefrien-geïnduseerde kontraksie en asetielkolien-geïnduseerde verslapping blootgestel was.  
Rot serum was vir biochemiese analises versamel.  Deelnemers van die menslike studie was gewerf, 
waarna bloedmonsters deur ‘n opgeleide verpleegster geneem is.  Bloeddruk en antropometriese 
metings was bepaal, en bloedmonsters was vir biochemiese analise voorberei. 
Resultate 
ART behandeling het tot ‘n vergrote infarkt grootte gelei [Kontrole (% risiko-area): 28.17±5.10, ART: 
50.56±4.08).  Hierdie resultaat was nie waargeneem in die Rooibos+ART groep nie.  Aorta ring 
eksperimente sonder PVAT het getoon dat ART verslapping verminder het in vergelyking met kontrole 
diere (p=0.03), terwyl kombinasie behandeling met rooibos hierdie effek opgehef het (p=0.003).  
Rooibos behandeling het in vergelyking met kontrole (p=0.01), ART (p=0.0457) en die kombinasie 
(p=0.0468), tot verhoogde kontraksie van aortas gelei.  In die teenwoordigheid van PVAT, het al die  
groepe minder verslap as die Kontrole+PVAT groep; Rooibos+PVAT groep (p<0.0001), ART+PVAT 
(p<0.01) en Rooibos+ART+PVAT (p<0.01). Area onder die kurwe (AOK): Kontrole+PVAT, 0.00099; 
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Rooibos+PVAT: 0.00079; ART+PVAT, 0.00091; ART+Rooibos+PVAT, 0.00088. Rooibos en ART 
behandeling het tot verhoogde kontraksie in vergelyking met kontrole diere gelei (p=0.006 en p=0.03 
onderskeidelik). AOK: Kontrole+PVAT, 31.45; Rooibos+PVAT: 43.42; ART+PVAT, 36.32; 
ART+Rooibos+PVAT, 33.34.  Die teenwoordigheid van PVAT het oor die algemeen tot ‘n verlaging in 
kontraksie gelei [Kontrole+PVAT versus Kontrole-PVAT (p<0.0001); Rooibos+PVAT versus Rooibos-
PVAT (p<0.0001); ART+PVAT versus ART-PVAT (p<0.0001); Rooibos+ART+PVAT versus Rooibos+ART-
PVAT (p<0.0001)].  In vergelyking met ander groepe, het Rooibos behandeling tot ‘n betekenisvolle 
verlaging in totale cholesterol gelei (p=0.048).  Epidemiologiese data het gewys dat ongeag MIV-status 
en ART behandeling, het rooibos geen effek op kardiovaskulêre parameters van pasiente nie. 
Bespreking en gevolgtrekking 
Die anti-verslappende effekte van ART was nie waargeneem in die teenwoordigheid van rooibos 
aanvulling nie.  ART behandeling het tot vergrote infarkte gelei.  Rooibos behandeling het tot ‘n pro-
kontraktiele effek gelei, terwyl PVAT tot ‘n verlaging in kontraksie gelei het.  Geen skadelike effekte 
geassosieer met die huidige ART regime was in die epidemiologiese studie waargeneem nie en verder 
het rooibos inname geen betekenisvolle effek op kardiovaskulêre parameters van pasiente gehad nie.  
Verdere navorsing word benodig. 
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Chapter 1 – Introduction 
 
1.1. Background 
 
1981 marked the year when mankind first became aware of the disease that would later be the heated 
topic of investigation amongst the medical and scientific community for more than 3 decades (Fauci 
2003; Gresele et al. 2012). It was then, now thirty five years ago that Acquired Immune Deficiency 
Syndrome (AIDS) was first described and scientists embarked on the seemingly insurmountable task 
of understanding the disease and then later developing a treatment (Fauci 2003). Number of deaths 
attributable to AIDS quickly rose to devastating proportions. In 1996 the introduction of new drug 
combinations- Highly Active Antiretroviral Therapy (HAART), which targeted the replication and 
spread of the virus, caused a massive decline in deaths due to Human Immunodeficiency Virus 
(HIV)/AIDS (Lopez 2011). 
 
This treatment gave HIV sufferers new found hope as their life expectancy was increased and the view 
of AIDS as a death sentence overthrown (Kallings 2008; Lopez 2011). The first few years of 
antiretroviral therapy (ART) involved infected patients taking as many as 30 tablets a day with large 
amounts of water and very unpleasant resultant side effects (Kallings 2008). Today, however, HIV 
sufferers need only take one tablet containing the combination of three or more drugs and therapy is 
much more effective (Kallings 2008; Schulenberg & Le Roux 2008). 
 
 Statistical figures clearly demonstrate a significant decrease in AIDS related deaths post 2005 when 
an increased rollout of antiretroviral (ARV) drugs occurred in South Africa, where 2005 had a 50.7% 
AIDS deaths (Statistics South Africa 2015). In mid-2015 the percentage of people dying due to AIDS 
was 30.5%. This is a positive sign but the 2015 report by Statistics South Africa further ascertains that 
an increased number of AIDS related deaths may be occurring 10 years post-ARV rollout (Statistics 
South Africa 2015).  
 
Substantial amount of scientific evidence now shows that whilst ART allows for the chronic 
management of HIV infection, their prolonged use results in certain toxicities and negative impacts on 
the body. Amongst the reported cases are nephrotoxicity, development of hypersensitivity to certain 
ART classes and lipodystrophy (Margolis et al. 2014; Meintjes et al. 2014). Furthermore and perhaps 
of greater implications are the findings that long term ART is linked to myocardial infarctions (MI), and 
increased risk factors for non-HIV related diseases (Lopez 2011). 
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There are three emergent schools of thought regarding ART and cardiovascular health; 1) reactive 
oxygen species (ROS) driven toxic effects of long term ART results in pro-inflammatory effects on the 
endothelium and endothelial function thus increasing risk for cardiovascular disease (CVD) 
(Schulenburg & Le Roux 2008) as well as the metabolic abnormalities seen in long term users (Currier 
et al. 2008), 2) cardiovascular and metabolic complications arising in long term HIV sufferers are not 
due to possible toxic effects of treatment but rather to low level of ROS driven chronic inflammation 
caused by the HIV itself (Aounallah et al. 2016) and 3) interplay of both the HIV and toxicities due to 
ART leads to the altered risk for CVD in HIV positive patients (Currier et al. 2008). 
 
Chronic inflammation is the principle driving force of cardiovascular disease in all these findings and 
although a consensus on the exact cause, whether long term ART, HIV or both, has yet to be made it 
is very clear that possible counter measures for ROS and thus inflammation have to be discovered and 
employed. For this reason it proves logical to investigate potent sources of antioxidants that may be 
able to intensify the body’s antioxidant capacity and thus alleviate the oxidative effects of ROS and 
consequent inflammation. 
 
Rooibos (Aspalathus linearis) is native to the Cederberg Mountains of the Western Cape where it 
grows as a shrub-like bush (McKay & Blumberg 2007). Apart from its many constituents rooibos 
contains vitamins, minerals and a high content of polyphenols which act as antioxidants (Standley et 
al. 2001; Barreira et al. 2013). It does not contain caffeine or other stimulants and has further been 
proven to have medicinal uses in the treatment of numerous ailments including HIV (Street & Prinsloo 
2013). The health benefits of rooibos supplementation during ARV treatment, however, remains 
largely unsubstantiated by scientific research, creating a need for the present study. 
  
1.2 Research Question 
 
What are the cardiovascular effects of Aspalathus Linearis/ rooibos infusion supplementation during 
ART, on male Wistar rats and the effects of rooibos tea consumption on the cardiovascular profiles of 
patients on ART? 
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1.3 Research Aims 
 
 Aim 1: To investigate the effects of rooibos tea supplementation, during first line fixed dose 
ART, on the isolated hearts and aortas of male Wistar rats. 
 Aim 2: To determine the effects of rooibos tea consumption on the cardiovascular profiles of 
patients on ART. 
 
1.4 Research Objectives 
 
 Aim 1 Objectives 
 
I. Treat rats for 9 weeks during which time the body weights and fluid intake are monitored by 
taking weekly measurements.  
II. Examine the functionality of the hearts through isolated heart perfusions. 
III. Conduct vascular reactivity studies to determine endothelial function and effect of 
perivascular adipose tissue (PVAT) on relaxation and contraction. 
IV. Through biochemical analyses determine the lipid profiles of the rats and thiobarbituric acid 
reactive substances (TBARS) levels as an indicator of lipid peroxidation. 
 
 Aim 2 Objectives 
 
V. To perform descriptive statistics on the study population. 
VI. Examine cardiovascular parameters and anthropometric parameters of patients. 
VII. Through biochemical analysis of patient’s serum determine lipid profiles and TBARS levels as 
an indicator of lipid peroxidation. 
 
1.5 Significance of the research 
 
Incidence of deaths attributable to HIV/AIDS is clearly increasing in the long term HIV positive 
population (Statistics South Africa 2015). Evidence shows that long term HIV/AIDS sufferers commonly 
develop CVD and complications (Currier et al. 2008; Aounallah et al. 2016). Few theories exist as to 
the exact causes, and even fewer theories postulating mechanisms leading to this increase in CVD. 
There is, therefore, a need for scientific studies that will examine possible relationships between ART, 
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HIV and CVD. The introduction of a new fixed dose combination (FDC), in SA in 2012, consisting of 
efavirenz, emtricitabine and tenofovir has further presented a need for research into the specific 
effects of this ART (Clinicians Society 2013). This study enables us to look at the direct effects of this 
drug combination on the heart and aorta of male Wistar rats in the absence of HIV and might shed 
some insight as to the effects of the same treatment in HIV positive patients. 
 
Scientific studies have identified ROS as the key role player in the development of CVD in long term 
ART users (Currier et al. 2008; Aounallah et al. 2016). A plausible solution is to investigate possible co-
treatments that may target the excessive ROS generation in this population. This research provides 
such an investigation using a drink that is affordable, with growing acclaim in the scientific community, 
is indigenous to SA and is a potent source of antioxidants: rooibos tea (Ajuwon et al. 2015). Albeit 
scientific studies with rooibos tea are plentiful, few have examined the qualities of this tea in the 
context of ART and HIV/AIDS (Marnewick et al. 2011). 
 
1.6 Research Scope 
 
Within the scope of this study are the isolated heart perfusions to determine functional recovery and 
the vascular reactivity experiments for the determination of endothelial function. These experiments 
are performed in our own laboratory and are therefore cost effective and feasible. The collection of 
blood samples for lipid profile determination and TBARS analyses allows us to gain as much 
information as possible from the same set of rats. The biochemical analyses are performed externally 
by a chemical pathologist to eliminate chances of error because the procurement of samples is a time 
consuming and costly process. 
Objectives that fall outside of the scope of the study and thus represent limitations include 
determining the signaling pathways or molecules activated in the various treatment groups. This did 
not form part of the objectives of this study because of time constraints and the resultant work load 
would surpass that which is required for an MSc thesis. Examining other measures of oxidative stress 
also do not fall within the scope of this study because of monetary constraints. 
 
The epidemiological study is a cross-sectional study focused on a study population from Durbanville, 
Fisantekraal, Elsies River, Uitsig, Bishop Lavis and Ravensmead. This study formed part of a parent 
study, termed “EndoAfrica”, which is coordinated by Prof Hans Strijdom and forms part of an 
international collaboration funded under the EU FP 7 programme. The study scope includes blood 
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serum analyses, determination of lipid profiles, recording of anthropometric measurements and 
determining the influence of life style choices on cardiovascular risk factors. 
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Chapter 2 – Literature Review 
 
The purpose of this review of the literature is to examine the reported effects of HIV and ART on the 
cardiovascular system and particularly on endothelial function and to review the capacity of 
Aspalathus linearis to counter oxidative stress.  
The review is structured so that the endothelium and the role of perivascular adipose tissue (PVAT) in 
the vasculature are discussed first. This is followed by the topic of HIV and CVD. ART is then discussed 
before entering into the topic of oxidative stress and Aspalathus linearis as a counter measure against 
ROS induced CVD. 
 
2.1 The Endothelium 
 
The endothelium is a thin layer of cells which forms the inner lining of blood vessels and plays an 
important role in regulating vascular function (Huang 2003; van Hinsbergh 2012). It performs an array 
of general and specific functions including preserving blood fluidity, controlling the recruitment of 
inflammatory cells and adhesion molecules, post inflammatory healing as well as regulation of 
vasodilation (van Hinsbergh 2012).  
 
2.1.1 Endothelial Function 
 
The endothelium achieves vasodilation through nitric oxide (NO) release in vascular smooth muscle 
cells (VSMC) (Sena et al. 2013). The enzyme endothelial nitric oxide synthase (eNOS) produces NO 
(Sena et al. 2013). eNOS is activated after increased levels of Ca2+ in the cytoplasm and facilitates 
binding of calmodulin to the enzyme (Sena et al. 2013).  It produces NO by firstly adding a hydroxyl 
group to L-arginine to form N”-hydroxy-L-arginine, the second step involves the oxidation of N”-
hydroxy-L-arginine by eNOS to produce L-citrulline and NO (Förstermann & Sessa 2012). NO activates 
soluble guanylyl cyclase (sGC) causing increased levels of cyclic guanosine-3,5-monophosphate 
(cGMP) (Sena et al. 2013). This in turn results in relaxation of VSMC through opening of K+ channels 
and membrane repolarization  (Sena et al. 2013). 
 
NO is a signaling molecule that has many targets and is involved in a number of processes but with a 
very short half-life of about less than 4s before it is converted to nitrite (NO2-), then nitrate (NO3-) and 
ultimately excreted in the urine (Sena et al. 2013). It has anti-inflammatory and anti-atherosclerotic 
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effects through the inhibition of endothelial cell apoptosis (Förstermann & Sessa 2012). Other 
functions of NO include control of vascular smooth muscle proliferation (Förstermann & Sessa 2012).  
 
2.1.2 Endothelial Function and Inflammation 
 
Inflammation is a multifactorial response to a disturbance in tissue homeostasis resulting from either 
infection by microbes, injury or trauma or exposure to foreign particles, irritants or pollutants. The 
primary function of inflammation is to restore homeostasis by destroying or isolating the source of 
the disturbance. (Ashley et al. 2012) 
 
Pro-inflammatory markers are produced in cases of infection, trauma or stress. Of particular 
importance is interleukin-6 (IL-6). IL-6 together with C-reactive protein (CRP) have been proven to act 
directly on NO decreasing its bioavailability and thus impairing endothelial vasodilation. CRP is an 
inflammatory marker that is produced by hepatocytes following stimulation by IL-6. It is used as a 
biomarker for endothelial dysfunction (ED) and can also be used as a cardiovascular risk factor 
(Lagrand et al. 1999). In pathophysiological states, characterised by increased inflammation, an 
increased synthesis of cells, cytokines and pro-inflammatory molecules ensues causing an increase in 
IL-6 and CRP production. This in turn feeds back to further exacerbate the inflammatory response thus 
creating an inflammatory cycle. (Teixeira et al. 2014) 
 
Scientific studies have revealed a clear relationship between inflammation and endothelial 
dysfunction and inflammatory markers have been proven to directly cause a decrease in eNOS activity 
thus reducing NO bioavailability and catapulting the ED process (Teixeira et al. 2014).  
 
2.1.3 Endothelial Dysfunction 
 
ED occurs when there is an imbalance between the vasoconstricting and vasodilating factors of the 
vasculature. It is characterized, chiefly, by an impairment in NO bioavailability with, amongst other 
characteristics, lowered endothelium-mediated vasorelaxation and increased ROS leading to 
augmented oxidative stress environment with greater expression of inflammatory genes. (Sena et al. 
2013) 
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The underlying mechanisms of ED include the trapping of NO by free radicals, chiefly via superoxide 
(O2-) binding with NO to form peroxynitrite (ONOO-) (further discussed in section 2.6.1 Oxidative 
Stress: Definition and Causes ) and reduced eNOS activity. (Huang 2003) 
 
2.2 Role of Perivascular Adipose Tissue (PVAT) in the Vasculature 
 
Perivascular adipose tissue (PVAT) is the layer of adipose tissue surrounding most blood vessels. There 
are three different categories of PVAT that are classified in rodents according to the anatomical 
locations. The classifications are: brown PVAT located around the thoracic aorta and has the functions 
and characteristics of brown adipose tissue (BAT), white PVAT which is similar to white adipose tissue 
(WAT) and surrounds small arteries and lastly beige PVAT which is found around the abdominal aorta, 
this is a mixture of BAT and WAT. Scientific evidence points towards human PVAT having 
characteristics of both WAT and BAT. (Brown et al. 2014) 
 
PVAT plays important roles in vascular function. The many functions of PVAT include offering 
mechanical protection to blood vessels by preventing contact induced friction with neighboring 
vessels, release of factors which cause vasodilation and influence VSMC contraction, proliferation, 
migration and thermoregulation. Furthermore, autocrine or paracrine effects through its release of 
several specific molecules and contractile effects (Brown et al. 2014). There are studies supporting 
both the contractile and vasodilator effects of PVAT (Rajsheker et al. 2010).  
 
In healthy individuals and under normal physiological conditions, PVAT produces a factor called 
adipocyte-derived relaxing factor (ADRF). This factor has been proven to induce relaxation of the 
vasculature through its activation of VSMC K+ channels thus inhibiting contraction. A study published 
in 2007 was able to demonstrate that ADRF can be transferred from one intact endothelium to the 
next and its induction not only dependent on an intact endothelium but also on endothelial nitric 
oxide release. Studies have further shown that the dilator effects of PVAT are lost under pathological 
conditions, most specifically in the presence of obesity. (Rajsheker et al. 2010) 
 
PVAT dependent contraction in the vasculature has been demonstrated, through studies of PVAT in 
dogs, to be ROS mediated (Rajsheker et al. 2010). In a more recent study published in 2014 authors 
sought to determine the mechanism of PVAT regulation of vascular tone (Lee et al. 2014). They 
performed isometric tension studies on isolated thoracic aortas (with and without PVAT) of male 
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Wistar rats and found that the PVAT caused increased vasoconstriction and inhibited vasodilation by 
attenuating NO production (Lee et al. 2014). 
 
2.3 HIV 
2.3.1 Introduction 
 
There are two different subtypes of HIV, HIV-1 and HIV-2 with HIV-1 being the most common type and 
HIV-2 being closely related but typically found in West Africa (Takhar & O’Laughlin 2014). This review 
will refer only to HIV-1 by simply using the term ‘HIV’. HIV is transmitted through direct contact with 
either the blood stream or contact and attachment to the mucosal surface (Dau & Holodniy 2008). A 
mature HIV virion is composed of an inner core surrounded by a viral membrane and an outer 
envelope. The core contains two copies of RNA, the enzymes reverse transcriptase and integrase, and 
regulatory proteins. The viral membrane surrounding the core contains the glycoproteins gp41 and 
gp120 (Fig. 2.1.) (Takhar & O’Laughlin 2014).  
                                          
Fig. 2.1. The HIV virion (Takhar & O’Laughlin 2014). 
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The HIV envelope has an affinity for the CD4 receptor (Arts & Hazuda 2012). During infection the virus 
fuses to the target cell surface through attachment of its glycoproteins to CD4+ glycoproteins and co-
receptors. The outer envelope fuses with the target cell membrane thus facilitating the entry of the 
inner core into the host cell. Once inside, reverse transcriptase transcribes the viral RNA into DNA 
which is transported by integrase into the nucleus of the host cell. Viral DNA then integrates into the 
host DNA. New viral particles are created through the formation of viral polyproteins and RNA which 
are modified and spliced by the viral enzyme protease. The mature virus is thus formed and the cycle 
restarted. After infection the virus destroys host CD4+ T-cell. The mechanism leading to this 
destruction is still unclear. (Takhar & O’Laughlin 2014) 
 
2.3.2 Mechanisms of HIV Induced CVD 
 
 Once an individual is infected with a virus the body’s immune system reacts as a defense against the 
disease. The innate immune system is the first line of defense and the cellular components thereof 
regulate transcription factors responsible for the production of interferons and cytokines (Thompson 
et al. 2011). Cytokines act as a cell stimulus which activate nuclear factor-kappa beta (NF-κβ) (Barnes 
& Karin 1997; Hoesel & Schmid 2013). The HIV protein Trans-Activator of Transcription (Tat) further 
stimulates the production of Tumor necrosis factor alpha (TNF-α) and NF-κβ (Gresele et al. 2012). 
 
NF-κβ plays a crucial role in the pathogenesis of persistent inflammation and metabolic disorders in 
chronic disease states. It primes and causes the subsequent activation of a specific cellular component 
of the innate immune system termed the nucleotide oligomerization domain-like receptors 
(NLRs/NACHT). Once primed this cellular component then forms the NLRP3 inflammasome- a multi-
domain complex chiefly responsible for initiating the maturation of the inflammatory markers 
interleukin 1β (IL-1β) and interleukin 18 (IL-18). This persistent production of IL-1β and IL-18 further 
stimulates NF-κβ resulting in a feedback system. This is the proposed mechanism by which chronic 
illness induced by viral infection, such as in the case of HIV infection, leads to tissue inflammation, 
damage and diseases including CVD. (Aounallah et al. 2016) 
 
This link between HIV infection and CVD is reflected in the health records of HIV positive versus HIV 
negative individuals pertaining to the Kaiser Permanente (KP) data base, an electronic data base 
containing health records of more than 30 000 000 members in 8 regions of the United States (US). 
Records show a significantly higher hospitalisation rate for both coronary heart disease and 
Stellenbosch University  https://scholar.sun.ac.za
11 
 
myocardial infarction in HIV positive members as opposed to HIV negative members. Cerrato et al. 
2013 illustrate this link and demonstrate how persistent immune activation and endothelial 
dysfunction together with inflammation stimulate the pathogenesis of coronary artery disease in HIV 
positive patients (Fig 2.2.) (Cerrato et al. 2013). 
 
It has been found that in the case of chronic inflammation, the metabolism of inflammatory immune 
cells is altered to one that is reliant on aerobic glycolysis as a response to their increased energy needs. 
This metabolic profile is characterised by a disturbed Krebs cycle that leads to a build-up of ROS, 
succinate and citrate. This further drives inflammation through the stabilisation of hypoxia-inducible 
factor 1α (HIF-1α) by mitochondrial succinate and increased NLRP3 inflammasome activation 
(Aounallah et al. 2016). ARTs are an effective treatment for CD4+ T-cell recovery but they do not fully 
counteract inflammation (Aounallah et al. 2016). These findings highlight the importance of 
developing a supplement or co-treatment for HIV that will counter the persistent inflammation.  
 
The study by Ross et al. 2008 had as part of its objectives to determine the role of HIV and ART in 
inflammation and subsequently endothelial activation. The study enrolled 182 patients and measured 
plasma levels of inflammatory cytokines and endothelial activation markers. Study groups were HIV+ 
on ART with HIV-1 RNA <1000 copies/mL with and without clinical lipoatrophy, HIV+ ART naive, and 
healthy controls. The results of this study suggested that endothelial dysfunction in the HIV positive 
group is driven by uncontrolled viremia and heightened inflammation. (Ross et al. 2008) 
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Fig. 2.2. Pathogenesis of coronary artery disease in HIV patients. Abbreviations: HIV: Human 
Immunodeficiency Virus; HAART: Highly Active Anti-retroviral Therapy; CMV: Cytomegalovirus (Dau & 
Holodniy 2008). 
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Dau and Holodniy in their 2008 publication “The Relationship Between HIV Infection and 
Cardiovascular Disease” explore the direct effects of HIV on the endothelium. The reported effects 
include that of secreted HIV protein Tat and envelope glycoprotein gp120. Tat has been found to 
weaken vasorelaxation in porcine coronary arteries by significantly reducing eNOS mRNA whilst gp120 
causes endothelial damage by increasing the production of NO in activated macrophages and directly 
stimulating endothelial cells resulting in more leukocytes binding to the endothelium (Dau & Holodniy 
2008). Tat also causes the production of TNF-α and NF-κβ by mononuclear cells, this is reported to 
initiate an inflammatory response (Gresele et al. 2012).  
 
2.3.3 The Inflammatory Cycle in HIV Infection 
 
IL-1β and IL-18 play important roles in initiating the body’s second line of defence: the adaptive 
immune system (Thompson et al. 2011). IL-18 causes increased production of natural killer cells (NK) 
by interferon gamma (IFNγ) and plays a role in recruiting and activating neutrophils while IL-1β plays 
a role in activation of T-lymphocytes, recruitment of innate immunity cells and initiating a fever 
(Thompson et al. 2011). Studies have proven a direct correlation between CD8+ activation and HIV 
disease progression, furthermore, markers of activation and/or apoptosis of CD8+, CD4+, T cells, B cells 
and NK cells and monocytes are elevated in HIV infected individuals (Appay & Sauce 2008). 
 
Lymphocyte activation leads to the production of pro-inflammatory cytokines and chemokines and 
directly increases intracellular levels of NF-κβ. NF-κβ promotes HIV-1 replication by inducing increased 
viral transcription which in turn exacerbates immune activation, feeding back to increased viral 
transcription- a cycle is thus created (Fig. 2.3.). (Appay & Sauce 2008) 
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Fig. 2.3. The causes and consequences of immune activation in HIV progression (Appay & Sauce 2008). 
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2.4 ART 
2.4.1 The Different Classes of ART 
 
ART drugs have been developed to target different parts of the HIV life cycle and are divided into 
classes dependent on the step that they target (Arts & Hazuda 2012). There are five classes available 
in Southern Africa:  
 Entry inhibitors/ cell membrane fusion inhibitors- block viral entry into host cells  
 Nucleoside and non-nucleotide reverse transcriptase inhibitors (NRTI & NNRTI)- target the 
enzyme reverse transcriptase  
 Protease inhibitors (PI) - block proteolysis of the viral polyprotein inhibiting the production of 
viral particles.  
 Integrase inhibitors- inhibit the integration of viral DNA into the cellular DNA. (Arts & Hazuda 
2012; Meintjes et al. 2014)  
PIs are the most potent agents available and regimens with PI contain a fourth drug that serves as a 
“boosting” agent to inhibit their metabolism and boost drug levels (Arts & Hazuda 2012). HIV 
treatment is divided into three specific lines each characterized by different drug combinations 
(Meintjes et al. 2014). 
 
2.4.2 Different Lines of Therapy 
 
Initially commencement with first line ART treatment was dependent on the patients CD4 count, viral 
load, and willingness to commit to lifelong treatment (Dau & Holodniy 2008). According to WHO 
guidelines, however, initiation of first line of treatment is now recommended among all HIV positive 
adults regardless of CD4 cell count (World Health Organization 2015). This criteria may be changed at 
a later stage. 
 
The first line ART regimen is made up of two NRTI’s and one NNRTI with the preferred drugs being 
tenofovir diphosphate (TDF) + emtricitabine 5’-triphosphate (FTC or 3TC) + efavirenz (EFV) (Meintjes 
et al. 2014). These drugs are available as a FDC in a once daily, single tablet formulation (Deeks & Perry 
2010) and in 2012 was rolled out as the first line regimen for South Africa by the SA Department of 
Health (Clinicians Society 2013). The doses in this FDC tablet are efavirenz/emtricitabine/tenofovir: 
600mg/200mg/300 mg respectively (Deeks & Perry 2010).  
 
Efavirenz (EFV): NNRTI that is a noncompetitive inhibitor of HIV-1.  
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Emtricitabine (FTC or 3TC): NRTI that is a competitive inhibitor of HIV-1, stops viral DNA chain growth 
 
Tenofovir (TDF): NRTI competitively inhibits reverse transcriptase of HIV-1 stopping viral DNA chain 
growth. (Deeks & Perry 2010) 
 
The recommended second line of ART treatment are 2 NRTI’s and a ritonavir boosted PI and the 
change from first line to second line regimen only occurs after a long period of virological failure. The 
change to third line of therapy only occurs if there is virological failure caused by NRT and NNRTI or 
resistance to PI. ART’s have been developed with the purpose of reducing morbidity and mortality 
caused by HIV, to suppress viral load for as long and as much as possible and to further improve the 
quality of life of infected individuals by re-instating and maintaining immune function. (Meintjes et al. 
2014)  
 
2.4.3 Reported Effects of ART 
 
Human studies have proven the efficacy of ART but reported long term effects are a cause for concern. 
Reported side effects of ART range from effects on the central nervous system such as hallucinations, 
insomnia and drowsiness caused by efavirenz, renal dysfunction and acute renal failure caused by 
tenofovir as well as hyperlipidemia being a causative effect of PI’s (Dau & Holodniy 2008). More 
specifically the effects on the cardiovascular system have been investigated. 
 
HIV is reported to have pro-inflammatory effects which leads to endothelial activation. ART, in general, 
is reported to lower this endothelial activation, but this is still an active area of research (Dau & 
Holodniy 2008). Metabolic syndrome (MS) is used as a marker to identify individuals who are at risk 
of CVD and type 2 diabetes mellitus (T2DM) (Wand et al. 2007). Evidence shows MS to become 
significantly progressive within 3 years of ART, specifically with the NRTI’s didanosine and stavudine 
together with the NNRTI efavirenz or nelfinavir (Wand et al. 2007). The observed increased incidences 
of MS and obesity evident in the HIV infected population lacks clear evidences of whether it is as a 
result of the medication or the disease itself (Lopez 2011). The study by Ross et al. 2008, previously 
referred to in the section 2.3.2 Mechanism of HIV Induced CVD, found that although ART decreased 
markers of inflammation patients remained with heightened inflammation compared to controls. ART, 
particularly PI’s and NRTI’s, has been linked to myocardial infarctions and have been shown to increase 
risk factors for non HIV related diseases (Lopez 2011).  
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The study by Bastard et al. 2014 which sought to investigate the roles of personal factors and HIV 
infection severity on the inflammatory profile of long-term ART controlled patients found markers of 
inflammation and immune activation to be elevated in the long-term treatment controlled HIV-
infected patients compared to healthy controls. Surprisingly this elevation was related to demographic 
and behavioral factors and had no correlation with markers of severity of HIV infection. (Bastard et al. 
2014)  
 
The Cinical Trials Group Study 5152s aimed to evaluate the effects of three class-sparing ART regimens 
on endothelial function in HIV-infected patients in a randomized trial. Patients were randomly 
assigned to groups of either a PI-sparing regimen of NRTIs+ efavirenz, a NNRTI-sparing regimen of 
NRTIs+ lopinavir/ ritonavir or a NRTI-sparing regimen of efavirenz+ lopinavir/ ritonavir (Torriani et al. 
2008). Endothelial function was determined by measuring the brachial artery flow-mediated dilation 
(FMD) before starting ART and at 4 and 24 weeks of treatment. The study employed 82 patients and 
found that all three ART regimens improved endothelial function.  
 
It has, however, been reported that commencing HAART treatment increases endothelial activation 
and dysfunction, this was at a mean duration of 9 months. Whilst patients on HAART for longer periods 
showed signs of endothelial dysfunction. More evidence exists on the effects of PI exposures causing 
endothelial dysfunction, overall damage to the vasculature by its increase of ROS formation and 
metabolic abnormalities than any other class of ART. (Haser & Sumpio 2016) 
 
There is some scientific evidence for NRTI’s contributing to increased cardiovascular disease risk. A 
recent review on the effects of HAART and HIV on the heart described the possible mechanisms by 
which HAART causes atherosclerotic cardiovascular disease (ASCVD). These mechanisms are through 
lipodystrophy, dyslipidemia (which both cause an increase in circulating triglycerides and lipid 
derangements), through direct damage of mitochondrial DNA and insulin resistance. (Lambert et al. 
2016) 
 
It is currently difficult to find studies that have examined the cardiovascular effects of long term 
tenofovir-based first line ART. A particular study conducted in western Kenya has examined the 
efficacy of treatment and incidence of drug resistance in this therapy. The tenofovir-based treatment 
group was compared against a non-tenofovir-based group and a tenofovir-only group. The study 
found the tenofovir-based ART to be most efficient in viral suppression compared to the non-
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tenofovir-based group and have lower incidences of resistance compared to the tenofovir-only group. 
(Brooks et al. 2016)  
 
2.4.4 Mechanism of ART induced CVD 
 
Although the mechanisms by which ART causes increased risk for CVD and toxicities such as 
hepatotoxicity are largely unclear, recent evidences have begun to shed some light on this topic. The 
growing body of evidence linking ART to CVD demonstrate the central role of the endoplasmic 
reticulum (ER) in the underlying pathophysiological mechanisms. 
 
The ER is found in all cell types and is the organelle responsible for protein synthesis, translation, 
folding and trafficking. Proper functioning of the ER demands a strict control over the intraluminal 
oxidative environment and the high calcium concentration. Disturbances to the environment of this 
organelle occur through, amongst other factors, viral infections, oxidative stress, energy deprivation, 
calcium depletion and elevated protein trafficking. Disturbances to the ER lead to the accumulation of 
unfolded proteins within the ER - a biological state termed “ER stress”. In ER stress the cell activates a 
complex signalling network, which acts as a protective mechanism, known as the unfolded protein 
response (UPR). While this response seeks to restore ER homeostasis by increasing transcription of 
ER-chaperones, triggering the breakdown of misfolded proteins and decreasing protein translation, 
prolonged action triggers the activation of inflammatory pathways and ultimately leads to cell death 
by apoptosis. (Apostolova et al. 2013; Galán et al. 2014; Cimellaro et al. 2016) 
 
ER stress has, over the recent years, been recognised as a common feature in the inflammatory 
response underlying cardiovascular disease. Chronic ER stress also leads to the accumulation of ROS 
and plays a crucial role in inducing endothelial dysfunction. This mechanism is well depicted by 
Cimellaro et al (Fig 2.4.). (Cimellaro et al. 2016) 
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Fig. 2.4. Pathogenesis of ER stress mediated endothelial dysfunction (ED) and cardiovascular disease 
(Cimellaro et al. 2016). 
ER stress is both the cause and the effect of chronic inflammation and oxidative stress found in 
endothelial dysfunction. Metabolic risk factors also play a role in ED. ER: Endoplasmic Reticulum; GlcN: 
Glucosamine; LDL-G: Glycated Low-density lipoprotein; LDL-ox: Oxidized Low-density lipoprotein; LDL-
HOG: Oxidized and Glycated Low-density lipoprotein; NO: Nitric Oxide. (Cimellaro et al. 2016) 
 
This mechanism of ER stress mediated ED has been described in drug-induced toxicities and more 
specifically in ART induced toxicity (Cimellaro et al. 2016). EFV, being the NNRTI that is most widely 
used and a constituent of the once daily FDC tablet, was investigated in the induction of ER stress in 
human hepatic cells (Apostolova et al. 2013). The study treated primary human hepatocytes with 
clinically relevant concentrations of EFV and found ER stress markers to be elevated in the cells treated 
with EFV (Apostolova et al. 2013). Another study observed the same findings when exposing human 
hepatic cells to EFV and further linked it to mitochondrial dysfunction (Alegre et al. 2013). A study in 
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the UK exposed the rat heart H9C2 cell line to three different concentrations of EFV for 24 or 48 hours 
and observed a concentration dependant loss in cell viability and EFV induced apoptosis and necrosis 
(Bergin et al. 2015). 
 
2.5 Oxidative Stress 
 
2.5.1 Definition and Causes 
 
Free radicals are chemical species that contain an unpaired electron in their outer orbital. These 
chemicals are very unstable and react with larger molecules thus oxidizing them and forming other 
free radicals. They are formed from four elements; oxygen to form reactive oxygen species (ROS), 
nitrogen, sulphur and chlorine to form reactive nitrogen species, reactive sulphur species and reactive 
chlorine species respectively. Of the four types ROS and RNS are the most relevant to cellular biology, 
with ROS being of greatest significance. (Ajuwon et al. 2015) 
 
Reactive oxygen species (ROS) are free oxygen radicals, oxygen ions and peroxides. At moderate levels 
ROS are important in maintaining tissue homeostasis. These signaling molecules play key roles in 
vascular tone, oxygen sensing, cell growth and proliferation, apoptosis and inflammatory response. 
There are a few sources of ROS in the vasculature and of major importance are the following enzyme 
systems: NADPH oxidase (Nox), xanthine oxidase (XO), enzymes of the mitochondrial respiratory 
chain, and irregular endothelial nitric oxide synthase (eNOS) activity (Li et al. 2014). When ROS derived 
oxidation outweighs antioxidant capacity oxidative stress occurs (Birben et al. 2012). 
 
Nox is made up of many proteins which assemble in the cell membrane to make up the active form of 
the enzyme (Li et al. 2013). It is expressed in various cell types including endothelial cells, smooth 
muscle cells and fibroblasts (Li et al. 2013). Of the existent isoforms of the enzyme Nox2 and Nox4 are 
mostly found in endothelial cells (Li et al. 2014). NADPH is used as an electron donor which transfers 
an electron to molecular oxygen thus producing superoxide (O2-) (Li et al. 2014). XO is expressed both 
in endothelium and in plasma and it too donates electrons to molecular oxygen producing O2- and 
hydrogen peroxide (H2O2) (Li et al. 2013). The liver synthesizes xanthine dehydrogenase which is 
converted to XO by proteolysis(Li et al. 2013). Evidence shows XO is expressed by endothelial cells and 
is up regulated with increased activity of Nox (Li et al. 2013).  
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The mitochondria produces ROS via the mitochondrial electron transport chain (ETC). Although ROS is 
produced by other electron complexes and mitochondrial enzymes (Ajuwon et al. 2015) the chief 
emitters of ROS are complexes I and III. Both complexes emit ROS in the form of O2- into the 
mitochondrial intermembrane space during energy transduction. ROS production by the mitochondria 
varies depending on a number of factors including cardiovascular risk factors, electron donor 
availability and uncoupling proteins. (Li et al. 2013) 
 
NOS proteins have three different isoforms, namely neuronal NOS (nNOS), inducible NOS (iNOS) and 
endothelial NOS (eNOS) all of which are homodimers (Förstermann & Sessa 2012). Under normal 
physiological conditions eNOS produces NO. In conditions of oxidative stress, however, eNOS is 
converted from an enzyme that produces NO to one that produces O2- (Förstermann & Sessa 2012). 
The process of its conversion is termed “NOS uncoupling” and to date quite a few mechanisms for this 
process have been described (Förstermann & Sessa 2012).  
 
In essence the process occurs through the oxidation of NO in the presence of excess O2- to produce 
peroxynitrite (ONOO-) (Li et al. 2013). One of the mechanisms by which ONOO- can lead to eNOS 
uncoupling is through the oxidation of the essential cofactor BH4 rendering it biologically inactive 
(Förstermann & Sessa 2012). NO bioavailability is further reduced in that ROS accelerate the 
breakdown of NO (Sena et al. 2013).   
 
2.5.2 Biomarkers of Oxidative stress 
 
There are two ways in which oxidative stress can be quantified biologically; one is by measuring 
molecules that are modified through interaction with ROS in the microenvironment (DNA, lipids, 
proteins and carbohydrates) and the second is by measuring the alteration in molecules of the 
antioxidant system as they respond to increased redox stress. One such change in molecules reacting 
with ROS occurs in lipids and is known as lipid peroxidation. In this process lipids are readily oxidized 
by free radicals because of the large presence of reactive double bonds in their molecular structure. 
(Ho et al. 2013) 
 
The most well-known markers of lipid peroxidation are isoprostanes (IsoPs) and malondialdehyde 
(MDA). IsoPs are products of arachidonic acid, a fatty acid found in the phospholipids of cell 
membranes, peroxidation. They are released into circulation by phospholipases and can thus be 
quantified in tissues, urine and blood samples. Such quantification can be achieved via mass 
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spectrometry, enzyme-linked immunosorbance assays (ELISA) and radioimmunoassay in plasma and 
urine samples. Both animal and human studies have validated this correlation between IsoPs levels in 
urine and plasma with in vivo oxidative stress levels. (Ho et al. 2013) 
 
MDA is the product of polyunsaturated fatty acid peroxidation. It can react with a number of proteins. 
The most significant reaction of MDA in the quantification of oxidative stress is its reaction with 
thiobarbituric acid (TBA) generating TBA reacting substances (TBARS). TBARS can be quantified in 
plasma through colorimetric assay and MDA can be detected with the use of high-performance liquid 
chromatography (HPLC) as well as a number of ELISA kits. (Ho et al. 2013) 
 
2.5.3 Antioxidants 
 
The counter mechanisms employed against ROS are antioxidants. There are endogenous and 
exogenous sources of antioxidants (Ajuwon et al. 2015). The body produces a number of different 
antioxidant enzymes, these are superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase 
(GPx), and paraoxonase (PON). There are three different isoforms of SOD depending on the transition 
metal found in the active site; SOD1 or copper-zinc-SOD (Cu-Zn-SOD) is found in the cytoplasm and in 
the mitochondrial intermembrane space, SOD2 or manganese-SOD (Mn-SOD) is located in the 
mitochondrial matrix and SOD3 or extracellular-SOD (EC-SOD) is mainly expressed in the extracellular 
matrix. All superoxide dismutases catalyse the conversion of O2- to O2 and H2O2. (Li et al. 2013; Li et al. 
2014) 
 
Catalases catalyse the degradation of H2O2 to O2 and H2O (Ajuwon et al. 2015). Catalases have a low 
affinity for hydrogen peroxide and thus are most efficient when there is an accumulation of the 
peroxide (Ajuwon et al. 2015). GPx degrade free H2O2 to water and lipid hydro peroxides to their 
alcohol derivative (Li et al. 2013; Li et al. 2014). GPx uses GSH and other thiols to reduce H2O2 (Ajuwon 
et al. 2015). This decomposition of H2O2 requires two GSH molecules and produces GSSG (Ajuwon et 
al. 2015). The GSH:GSSG ratio is used as an indicator of redox activity (Ajuwon et al. 2015). GSSG can 
be reduced back to GSH by the enzyme glutathione reductase (Ajuwon et al. 2015). 
 
The localisation and actions of the three different forms of PONS differs. PON1 is predominant in high 
density lipoproteins (HDLs) where it acts as a defence against the peroxidation of HDL and low density 
lipoproteins (LDLs) by breaking down cholesteryl esters and phospholipids in oxidized lipoproteins (Li 
et al. 2013; Li et al. 2014).  
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The endogenous sources of antioxidants may not be sufficient to counter elevated levels of ROS 
formation, especially in disease states. It is, therefore, important to consume exogenous/dietary 
antioxidants. The most well-known sources of diet-derived antioxidants are vitamins C (ascorbate), E, 
A and carotenoids. Vitamin C scavenges free radicals by donating one of its electrons and thus 
becoming oxidised to an ascorbate radical (Asc-). NADH- and NADPH-dependent dehydroascorbate 
reductase reduces Asc- back to ascorbate. Vitamin E contains an –OH group which it uses to reduce 
lipid peroxyl groups to hydro peroxides. (Ajuwon et al. 2015) 
 
An additional exogenous source of antioxidants that has proven to have potent health promoting and 
antioxidant effects over the years are plant derived phenolics and polyphenols. Of particular interest 
and with great health implications are polyphenols derived from Rooibos (Aspalathus linearis). 
(Ajuwon et al. 2015) 
 
2.6 Aspalathus Linearis  
 
2.6.1 Introduction 
 
Aspalathus linearis is a plant that is indigenous to South Africa and from which the renowned Rooibos 
infusion is produced. In its natural/unfermented state it is a green infusion and the traditional red-
brown color is obtained through the process of fermentation (Villaño et al. 2010). Albeit its agricultural 
value was discovered in 1930 this infusion is now famous for its taste, antioxidant, vitamin and mineral 
content as well as its lack of caffeine and other stimulants (Street & Prinsloo 2013).  
 
Components of rooibos that are responsible for its anti-oxidant capacity are known as polyphenolic 
compounds or polyphenols (Villaño et al. 2010). Their chemical structure contains one aromatic ring 
attached to one or more hydroxyl groups (Del Rio et al. 2013). Phenolic compounds are subdivided 
into flavonoids and non-flavonoids (Del Rio et al. 2013). The principle flavonoids present in Rooibos 
infusion are aspalathin, nothofagin, C-linked glycosides of the flavones, epigenin and luteoilin and four 
eriodictyol-C-glycoside isomers (Villaño et al. 2010). 
 
2.6.2  Processing 
 
Processing of rooibos involves first shredding of the plant shoots into 3-4mm lengths which are then 
placed in a fermentation heap where the inner and outer structures of the leaves are broken down 
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through “bruising”. This takes place in the late afternoon. Water is added and more bruising takes 
place in order to speed up the fermentation process which already begins with the shredding of the 
leaves. Fermentation occurs during the night and in the morning the infusion is left to dry in the sun. 
The fermentation process can last from 8-24 hours. (Joubert & Schultz 2012)  
Although studies have proven that the unfermented rooibos infusion has a more potent antioxidant 
capacity than the fermented variant both the fermented and the unfermented variant have proven 
antioxidant effects in vivo (Villaño et al. 2010).  
 
The most active compounds in Rooibos are aspalathin (Asp) and nothofagin (Not). The process of 
fermentation extensively oxidizes aspalathin whilst the nothofagin is affected to a lesser degree. 
(Ajuwon et al. 2015) 
 
2.6.3 Bioavailability and Antioxidant Potential After Consumption 
 
Absorption of some polyphenol metabolites into the circulation occurs in the small intestine. Initial 
metabolism takes place in the brush border of the small intestine, thereafter metabolites enter the 
circulation and quickly reach the liver where they are further metabolised. Even with absorption 
occurring in the small intestine most of the polyphenols pass through to the large intestine where they 
are cleaved into smaller molecules by colonic microbiota. Further metabolism then takes place in the 
liver before the metabolites are excreted in the urine. (Del Rio et al. 2013) 
 
2.6.4 Anti-inflammatory Capacity 
 
A study by Lee & Bae 2015 tested the anti-inflammatory effects of both these compounds in vivo- on 
mice and in vitro on LPS- activated human umbilical vein endothelial cells (HUVECs). Studies have 
found that Asp and Not inhibited LPS-induced hyper permeability thus favoring endothelial integrity 
and tissue homeostasis, suppressed leukocyte migration and inhibited the activation of TNF-α or 
interleukin (IL)-6 and NF-kβ or ERK. The authors concluded that Asp and Not can be used as a therapy 
for vascular inflammatory diseases. (Lee & Bae 2015) 
 
Although a substantial amount of research still needs to be done in order to investigate the anti-
inflammatory properties of herbal teas using animal models the mechanism by which tea polyphenols 
inhibit NF-κβ activation and thus inflammation has been explored (Gonzalez De Mejia et al. 2013).  
Gonzalez De Mejia et al. in their 2013 publication, Tea and Inflammation, illustrate how tea 
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polyphenols inhibit markers of inflammation related to NF-κβ. The mechanism involves the inhibition 
of ROS, IL-1β and TNF-α by tea polyphenols. The inhibition of these substances inhibits NF-κβ 
activation and translocation into the nucleus thus preventing the transcription of inflammatory genes. 
As a consequence of this repression the production of cytokines and adhesion molecules is reduced 
and thus inflammation repressed as well (Fig. 2.5). (Gonzalez De Mejia et al. 2013) 
 
2.6.5 Effects on oxidative stress and ischemia 
 
Aqueous extract of fermented rooibos infusion has been tested in the context of diabetic 
cardiomyopathy (DCM) (Dludla et al. 2014). The study treated cultured cardiomyocytes, isolated from 
adult Wistar rats that had been previously injected with streptozotocin (STZ) to induce diabetes, with 
an aqueous extract of fermented rooibos. Cardiomyocytes were then exposed to either hydrogen 
peroxide (H2O2) or an ischemic solution. The results showed that the aqueous extract of fermented 
rooibos protected the cardiomyocytes against oxidative stress and ischemia. (Dludla et al. 2014) 
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Fig. 2.5. Mechanisms by which tea polyphenols can inhibit NF-κβ driven inflammation (Gonzalez De 
Mejia et al. 2013). 
 
Rooibos has further been tested against ischemia reperfusion injury on hearts of male Wistar rats. A 
study by Pantsi et al. treated male Wistar rats with a 2% (2g/100ml) rooibos tea solution, by putting it 
in place of their drinking water, for seven weeks. The study tested four groups; a control- that received 
tap water, unfermented/”green” rooibos, fermented rooibos and green tea group with an n value of 
10 hearts per group. Hearts were perfused with Krebs-Henseleit buffer (KHB) and after stabilization 
exposed to 15 minutes of global ischemia. Aortic output recovery (AO) was measured as the functional 
parameter. The aortic recovery of hearts supplemented with both the unfermented and the 
fermented rooibos tea variants was significantly higher compared to that of the controls. (Pantsi et al. 
2011) 
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The effects of a similar study were reported in 2003 where rats were fed a 2% (w/v) aqueous extract 
of the fermented and unfermented rooibos for 10 weeks. Although no effects were observed in the 
antioxidant capacity of the liver both forms improved the redox status of the liver by significantly 
increasing the GSH:GSSG ratio. Effects of rooibos treatment in rats has also been tested against shorter 
treatment periods. One particular study pre-fed fermented rooibos to rats for 4 weeks and observed 
an inhibition in the formation of plasma and hepatic malondialdehyde (MDA). Postulated mechanisms 
by which rooibos counters oxidative stress is through the direct scavenging of ROS by polyphenols or 
their inhibition of lipid peroxidation. (Ajuwon et al. 2015) 
 
Ajuwon et al in their 2014 publication “Amelioration of lipopolysaccharide-induced liver injury by 
aqueous rooibos (Aspalathus linearis) extract via inhibition of pro-inflammatory cytokines and 
oxidative stress” reported findings that a 4 week supplementation of male Wistar rats with fermented 
rooibos extract produced an anti-inflammatory response countering the inflammation induced by 
lipopolysaccharide injection. This supplementation of a 2% (w/v) rooibos infusion effectively inhibited 
the increased production of pro-inflammatory cytokines, TNF-α and IL-6 but increased plasma levels 
of anti-inflammatory cytokine IL-10. (Ajuwon et al. 2014) 
 
There is a sparse body of studies that have investigated the health benefits of rooibos in humans and 
even fewer studies in the clinical setting of oxidative stress and cardiovascular disease risk. One such 
study has investigated the effects of 8 weeks of unfermented rooibos tea consumption, as an 
intervention, by workers who were occupationally exposed to lead. Investigators found an 
improvement in the workers antioxidant status, this was evident in an increase in SOD activity and 
GSH levels and decrease in MDA levels. (Nikolova et al. 2007) 
 
In another study, Marnewick et al. tested the effects of consumption of fermented rooibos on people 
who were at risk for cardiovascular disease. To achieve their aim they had 40 volunteers consume 6 
cups of rooibos daily for 6 weeks and after a control period they tested the blood biochemical 
parameters indicative of antioxidant activity, lipid peroxidation and lipid profile. Results showed that 
the plasma antioxidant capacity did not change but total polyphenol levels in plasma was increased. 
Furthermore there was a significant decrease in markers of lipid peroxidation mainly conjugated 
dienes (CD’s) and TBARS. Rooibos consumption also significantly reduced serum levels of low density 
lipoprotein (LDL) - cholesterol and triacylglycerols (TG) whilst significantly increasing high density 
lipoproteins (HDL) - cholesterol. (Marnewick et al. 2011) 
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2.7 Conclusion 
 
HIV infection causes an underlying low level of chronic inflammation which is not countered by ART 
(Dau & Holodniy 2008). ART, although being able to block viral replication and thus increase CD4 cell 
counts its long term use leads to an inflammatory burden and increased ROS production through ER 
stress induced mechanisms (Cimellaro et al. 2016). This stress manifests itself through ED ultimately 
being the chief cause of CVD in long term ART users (Cimellaro et al. 2016). Natural sources of anti-
oxidants as a supplement to ART still require considerable investigation within the laboratory setting. 
Of particular note the use of Rooibos has not been scientifically investigated in the settings of ART 
thus further highlighting the need for the present study. Rooibos polyphenols are able to counter 
inflammation and directly scavenge ROS and may, therefore, be able to prevent the pathogenesis of 
ED in long term ART users (Gonzalez De Mejia et al. 2013).  
 
Therefore, rooibos as a supplement during ART may provide the counter measure for oxidative stress 
induced ED thus improving antioxidant capacity of the organism and overall functioning of the heart. 
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Chapter 3 – Materials and Methods 
3.1 Materials 
Reagent/ Material Supplier 
2,3,5-Triphenyltetrazolium chloride (TTC; 
C19H15CIN4) 
Calcium chloride dihydrate (CaCl2.2H2O) 
D(+)-Glucose anhydrous (C6H12O16) 
Formaldehyde (CH2O) 
Sodium chloride(NaCl); Sodium bicarbinate 
(NaHCO3); Potassium chloride(KCl); Potassium 
dihydrogen phosphate(KH2PO4); Magnesium 
sulphate heptahydrate (MgSO4.7H2O); Sodium 
sulphate (NaSO4)  
Merck (Pty) Ltd. (Darmstadt, Germany) 
Acetylcholine 
Epinephrine 
Evans blue 
Sigma (St. Louis, MO, USA) 
 
Aspalathus linearis (Fermented Rooibos) 
 
Carmien Tea (Pty) Ltd. (Brakfontein Estate, 
Citrusdal, SA) 
Blood collection tubes 
Storage eppendorfs 
The Scientific Group (Pty) Ltd. (Milnerton, 
Western Cape, RSA) 
Consumables used for sample collection 
(tornequet, vacuette collection set, needles, 
gauze, plasters) 
Pharmacy City 
Ethicon Sutures Mersilk Johnson & Johnson  
  
 
Eutha-naze (Sodium pentobarbital; 
C11H17N2NaO3) 
Bayer (Pty) Ltd. (Isando, Gauteng, RSA) 
Odimune Tablets Cipla MedPro (Pty) Ltd.  (Bellville, Western Cape, 
SA) 
OMRON M6 automatic digital blood pressure 
monitor 
Omron Healthcare (Kyoto, Japan) 
Pathology transport box and pod Lab Specialist Services 
Stellenbosch University  https://scholar.sun.ac.za
30 
 
3.2 Methods 
 
3.2.1 Determining the effects of Aspalathus linearis supplementation during first line 
fixed dose ART on the isolated hearts and aortas of male Wistar rats. 
 
3.2.1.1 Ethics Clearance  
 
Approval for the use of male Wistar rats for this study was obtained from the Research Ethics 
Committee for Animal Care and Use, Stellenbosch University (Protocol #: SU-ACUD14-00021).  
 
3.2.1.2 Animal Husbandry 
 
The rats were housed in a facility that is Association for Assessment and Accreditation of Laboratory 
Animal Care (AAALAC) accredited and their handling was in accordance with the institutional ethical 
guidelines. Rats were treated from 4 weeks of age for 9 weeks during which time they had free access 
to food and water or rooibos tea, according to the treatment groups. All rats received normal rat chow. 
Rats were weighed and monitored for hair loss and other markers of stress weekly. The fluid intake 
was measured weekly.  
 
3.2.1.3 Odimune Preparation 
 
Odimune tablets contain the recommended daily dose of active ingredients (600 mg EFV, 200 mg FTC, 
and 300 mg TDF) for an average human (70kg). The specific dose for the rats was calculated and 
prepared weekly, according to the average total body mass of the rats per cage, using the USA FDA 
guidelines (Center for Drug Evaluation and Research 2005) (Appendix A: Odimune Dose Calculations). 
Each tablet was first crushed individually, the exact mass needed was determined based on the 
average mass per cage. The determined amount of powder was suspended in 1ml water/rat/day and 
vortexed thoroughly. The drug preparations were kept in a -4oC fridge and administered, via oral 
gavage, to the rats daily by a laboratory animal husbandry professional.   
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3.2.1.4 Rooibos Tea Preparation 
 
Fermented rooibos leaves were stored in a light proof sealed container at room temperature and 
under dry conditions. Rooibos infusion was either prepared weekly or two weeks in advance in which 
case it would be stored at -20oC. A fresh batch of rooibos infusion was allocated to the relevant 
treatment groups weekly. 
Aqueous extract of rooibos was made up using an already established method of preparation with a 
concentration that is customarily used for tea making purposes. A 2% (w/v) tea solution was made up 
each time by steeping 20g of the tea leaves into 1L of boiling tap water for 30 minutes. After steeping, 
the tea was filtered through a layer of cheese cloth, no.4 filter paper and a no.1 filter paper 
sequentially and then placed into light proof bottles. (Marnewick et al. 2003) 
 
Liquid chromatography mass spectrometry (LC-MS) analysis was conducted on the rooibos infusions 
after applying the storage methods used (fresh, fridge for 1 week or frozen at -20oC for more than 1 
week) showed no differences in polyphenols levels and the composition was comparable to that of 
rooibos infusions used in previously published data (Appendix B: LC-MS of Rooibos) (Beelders et al. 
2012).  
 
3.2.1.5 Animal Supplementation and Treatment 
 
The water or tea was poured into the rats drinking bottles (one bottle per cage) and bottles with the 
tea were covered with tin foil and masking tape in order to lightproof them. Bottles were filled with 
800-1000ml of water or tea, and fluid consumption was measured before the fluid was replaced 
weekly.  
ART was administered every morning by oral gavage. This procedure was performed by a professional 
and involves the delivery of the compound straight to the stomach by inserting a bulb tipped gastric 
gavage needle along the side of the mouth, into the esophagus and toward the stomach. Non-ART 
treated rats received oral gavage with tap water only. ART and rooibos supplementation were 
administered for 9 weeks and correlates with time periods used in several studies that investigated 
the effects of chronic supplementation of rooibos tea and obtained positive results (Ajuwon et al. 
2015).  
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3.2.1.6 Experimental Design 
 
The study made use of a total of 100 rats. Experiments were performed in 3 separate periods during 
1 year. Period 1: 36 rats, period 2: 32 rats, period 3: 32 rats. Rats were randomly assigned into four 
treatment groups (Fig 3.1): 
 Control (25 rats): gavaged with tap water and received tap water to drink 
 Rooibos (25 rats): gavaged with tap water and received rooibos  to drink 
 ART Control (22 rats): gavaged with ART and received tap water to drink 
 ART+Rooibos (24 rats): gavaged with ART and received rooibos to drink 
A total of 65 rats were used for perfusions, where 34 were used to determine functional recovery by 
the induction of regional ischemia and 31 by inducing global ischemia. Twenty two rats were fasted 
overnight and blood was collected from the thoracic cavity after sacrifice. The sum of 4 rats were lost 
to gavage during the different treatment periods. 
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Fig. 3.1. Experimental groups and sample sizes. * indicate number of animals lost to oral gavage whilst 
[] indicate the number of rats fasted overnight for serum collection and analysis. Abbreviations: ART: 
Antiretroviral Therapy; n: sample size. 
 
3.2.1.7 Euthanasia of Rats 
 
Rats were put to sleep with an injection of pentobarbital of 1ml/kg body weight concentration. The 
injection was done intraperitoneally and performed by an authorized professional of the South African 
Veterinary Council (SAVC) for paravetiranary procedures. To ascertain that rats were deep enough in 
sleep the toe pinch method was used.  Once no reflexes were observed hearts were removed by 
thoracotomy and rats sacrificed by exsanguination. 
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3.2.1.8 Perfusion Technique and Protocols 
 
Hearts were excised rapidly and arrested in ice cold Krebs-Henseleit buffer (KHB) before mounting 
onto the working heart perfusion system (Neely et al. 1967). The hearts were mounted by insertion 
of the aortic cannula into the aorta allowing for a retrograde perfusion in Langendorf mode at a 
constant pressure (100cm H2O) for 10min whilst insertion of the second cannula into the left atrium 
occurred (Zimmer 1998).  This was followed by 20min of working heart at a preload of 15cm H2O and 
an afterload of 100cm H2O.  
 
Mechanical function was noted through the recording of haemodynamic data and calculating of 
specific parameters. Coronary (Qe/CF) and aortic (Qa/AO) flow rates in ml/minute were measured 
manually whilst the peak systolic and diastolic pressures (PSP & DP) and the heart rate (HR) were 
recorded with a Gentronics chart recorder v3.00. The cardiac output (CO) (ml/min) = (Qa + Qe) and 
Stroke volume (SV) (ml/min) = (CO / HR). Total work (TW) was measured as a function of the cardiac 
output and systolic pressure: (TW= COxSPx0.0022). 
 
Hearts were subjected to either a 20min global ischemia period, where perfusion flow to the heart 
was blocked completely, or 35min of regional ischemia by occlusion of the coronary artery. Ischemia 
was succeeded by reperfusion as per the time periods indicated below (Fig. 3.2. and Fig. 3.3.). 
Haemodynamic data was recorded and parameters listed above calculated at each time period. 
 
3.2.1.8.1 Regional Ischemia 
 
In the infarct size protocols hearts were subjected to 35min of regional ischemia by occlusion of the 
coronary artery and succeeded by a reperfusion period of 60min (Bell et al. 2011). The induction of 
regional ischemia occurred through the insertion of a silk suture underneath and around the proximal 
left anterior (LAD) coronary artery. Tightening of the suture resulted in an occlusion of the coronary 
artery and subsequent cessation of myocardial perfusion in the surrounding region. During this period 
the temperature was monitored and kept at a constant 36.5oC. Effective occlusion of the vessel 
resulted in a 33% reduction in total coronary flow and cyanosis of the region. As per protocol, hearts 
were then re-perfused for 60min.  
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Measurement of risk zone and infarct size after regional ischemia 
The suture around the coronary artery was tied off and a 0.5% Evan’s Blue solution infused through 
the aorta to stain the viable tissue. The hearts were frozen overnight, sliced into 2mm thick slices and 
incubated in a 1% w/v triphenyltetrazoliumchloride (TTC) in phosphate buffer solution for 15 
minutes(pH 7.4) before being placed in 10% formalin. Heart segments were placed between two glass 
plates. The left ventricle area at risk (R) and the area of infarct (I) tissue were determined using 
computerised planimetry (UTHSCSA Image Tool program, developed at the University of Texas Health 
Science Center at San Antonio, Texas). Infarct size was expressed as a percentage of the area at risk 
(%AAR).  
 
Fig. 3.2. Experimental protocol of regional ischemia. Abbreviations: L: Langendorff; WH: Working 
Heart; R.I: Regional Ischemia 
 
3.2.1.8.2 Global Ischemia 
 
For the determination of functional recovery hearts were subjected to a 20min global ischemia period 
where perfusion flow to the heart was blocked completely. A 30min reperfusion period then took 
place before freeze clamping.  
 
Fig. 3.3. Experimental protocol of global ischemia. Abbreviations: L: Langendorff; WH: Working 
Heart; G.I: Global Ischemia 
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3.2.1.9 Aortic Ring Technique and Protocol 
 
For vascular reactivity studies the  protocol was adapted from Privett et al., in order to determine NO 
dependent vasodilation (Privett et al. 2004). This method of determining vascular response to 
contraction and relaxation is well established (Li et al. 2004; Ma et al. 2010; Rodrigues et al. 2014). 
Phenylephrine and acetylcholine were dissolved in 0.9% saline solution to make up the stock solutions. 
The thoracic aorta was carefully dissected and placed in a petri dish with ice cold KHB containing in 
mM/L: NaCl 119; NaHCO3 24.9; KCl 4.74; KH2PO4 1.19; MgSO4 0.6; NaSO4 0.59; CaCl2 1.25; glucose 10.  
 
To determine the role of perivascular adipose tissue (PVAT) the aortas of group one were sectioned 
in half. The one half was cleaned, under a magnifying glass, by the removal of PVAT and connective 
tissue whilst the other was left with part of the surrounding PVAT (Fig. 3.4A.). A 3-4mm segment from 
each half was cut for the experiment. Both the clean aorta and the ring containing the surrounding 
PVAT were mounted on two separate already calibrated aortic ring systems.  
 
Mounting involves placing the ring between two steal hooks and then lowering it into the organ bath 
(AD Instruments, Bella Vista, New South Wales, Australia) with KHB at 36.5-37°C gassed with 95% O2 
and 5% CO2 (Fig. 3.4B.). Aortic ring tension was recorded with an isometric force transducer 
(TRI202PAD, Panlab, ICornellà, BCN, Spain). The protocol (Fig. 3.5) begins with a 30 min stabilization 
period during which the tension was gradually increased to a resting tension of 1.5g and the KHB 
replaced with warmed buffer at 10 and 20 minutes. After stabilization the buffer in the organ bath 
was set at exactly 25ml and 2.5 μL of a 1mM Phenylephrine (Phe) stock, with a final concentration of 
100nM, was added to the organ bath. Once contraction reached a plateau 25μL of a 10nM Ach stock, 
with a final concentration of 10µM, was added and likewise relaxation was left to reach a plateau.  
The organ bath was flushed and rinsed with clean KHB three times, followed by another stabilization 
period of 30 min. The buffer was changed at 10 and 20 minutes and the tension maintained at a steady 
1.5g. After this second stabilization period, a cumulative contraction was induced by five consecutive 
additions of Phe with the concentrations; 100nM, 300nM, 500nM, 800nM and 1µM. This was followed 
by a cumulative relaxation period with five consecutive additions of Ach with concentrations; 30nM, 
100nM, 300nM, 1µM and 10µM. Results were analysed using LabChart Reader v8.1.2 (Dunedin, New 
Zealand) and GraphPad Prism 6. 
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Fig. 3.4. Images of aortic ring after cleaning and sectioning. A. Two 3-4mm aortic ring sections, one 
with surrounding PVAT and the other without. B. Aortic ring mounted between the two steel hooks 
just before its submergence into the organ bath. 
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Fig. 3.5. Depiction of the aortic ring protocol. After mounting, protocol begins with a 30min 
stabilization period which is followed by a 100nM addition of Phe and 10μM Ach once a plateau is 
reached. Another stabilization period of 30min ensues followed by a cumulative period of Phe addition 
of concentration ranging from 100nM-1μM and a cumulative period of Ach addition of a contraction 
range of 30nM-10μM. Abbreviations: Ach: Acetylcholine; Phe/Fe: Phenylephrine; Stab: Stabilization. 
(Westcott, C., 2015.  Investigating the cholesterol-independent (pleiotropic) effects of selected 
hypolipidaemic agents in functional and dysfunctional endothelial cells. PhD thesis, University of 
Stellenbosch.) 
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3.2.1.10 Blood Sample Collection, Preparation and Storage 
 
Blood samples were collected from the thoracic cavity of the rats and placed in serum separation 
tubes as follows: 
 1x3ml purple top EDTA tube (with anticoagulating factors): delivered to UCT for thiobarbituric 
acid reactive substances (TBARS) analysis 
 1x3ml red top Serum tube (with clot activating silicone): delivered to UCT for a phospholipid 
test 
The samples were then centrifuged in an IEC Model Clini-cool refrigerated centrifuge (4oC) for 15 
minutes at 3000rpm. Supernatants (plasma from EDTA tube and serum from red top Serum tube,) 
were stored at -80oC before being delivered to Division of Chemical Pathology at University of Cape 
Town (UCT) where the serum triglycerides (TRIG), phospholipids (PL) and TBARS concentrations were 
determined. 
 
3.2.1.11 Triglycerides, Phospholipids and TBARS 
 
Serum TRIG and PL concentrations were determined using enzymatic colorimetric kits and a SPECTRA-
maxPLUS-384 spectrophotometer with SoftMax pro 4.8 data acquisition and analysis software. In 
principle, performing the assay involved pipetting the TRIG standard and samples into the microwell 
plate, adding a diluted enzyme buffer solution to each well and incubating at room temperature 
before reading the absorbance. 
TBARS were measured according to the previously published method of Jentzsch et al. In this method 
plasma samples (200 μL) are mixed with 10 μL of butylated hydroxytoluene and vortexed for 10 
seconds. Thiobarbituric acid reagent is added before vortexing once again and then incubating in a 
water bath at 90oC for 45 minutes. Tubes are placed on ice to terminate the reaction, TBARS are 
extracted, NaCl added and the mixture is centrifuged at 10 000 g for 1 minute (Jentzsch et al. 1996). 
The absorbance was read at 532 nm and values were expressed in micro molar serum TBARS. 
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3.2.2 Determining the effects of rooibos tea consumption on the cardiovascular 
profiles of patients on first line fixed dose ART compared to controls 
 
The human study formed part of a parent study called EndoAfrica (project coordinator Prof Hans 
Strijdom), which is an international collaboration funded under the EU FP 7 programme. It enlisted a 
total of 105 participants of which 23 were HIV negative, 14 HIV positive ART naïve and 68 were HIV 
positive and on ART. Participants were recruited from Durbanville, Fisantekraal, Elsies River, Uitsig, 
Bishop Lavis and Ravensmead by a professional nurse. The nurse obtained written consent from the 
participants before enrolling them in the study. All participants were given study identities (study I.D). 
Anthropometric measurements, that is; height, weight, body mass index (BMI) and hip waist 
circumference as well as the cardiovascular parameters; diastolic, systolic pressure and heart rates 
were determined and recorded. Lifestyle indices relative to rooibos tea consumption and smoking 
were obtained via a questionnaire. Participant data was stored on an online data base called RedCap. 
Ethical approval was obtained from the Health Research Ethics Committee (HREC) (Reference number: 
N13/05/064). 
 
3.2.2.1 Inclusion and Exclusion Criteria 
 
The study excluded individuals who were less than 18 years of age, pregnant women and women who 
were less than 3 months post-partem. HIV positive and negative patients who did not fit this criteria 
were all included. 
 
3.2.2.2 Biological Sample Collection 
 
Participants fasted overnight. Blood samples were collected by a phlebotomist. The samples were 
collected and tubed as follows:  
 2x5ml purple top EDTA tube: sent to the National Health Laboratory Service (NHLS) to test 
haemoglobin, PLG CD4, HBA1C, HIV viral load 
 1x7ml yellow top Serum tube: sent to NHLS for fasting lipogram, creatinine and GGT test 
 1x5ml grey top: sent to NHLS for fasting glucose test 
 1x10ml purple top EDTA tube (with anticoagulating factors): sent to Department of Chemical 
Pathology, UCT for TBARS analysis 
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 1x3ml red top Serum tube (with clot activating silicone): sent to Department of Chemical 
Pathology, UCT for a phospholipid test 
 
Tubes were inverted 8 times before being placed in a plastic bag with an absorbent strip. The bag was 
sealed and placed in a hard cover pod which was then placed in a pre-cooled pathology transport box 
containing two ice packs. Samples were then driven, together with the participant, from the local clinic 
to Tygerberg Medical Campus, Division of Medical Physiology. At Tygerberg all samples were labelled 
with the study I.D, barcoded and logged onto a computerized data base called REDCap. After sample 
logging the purple, yellow and grey top sample tubes were delivered to NHLS for testing as per the 
above indications 
 
3.2.2.3 Sample Preparation and Storage 
 
The 1x10ml purple top EDTA tube and the 1x3ml red top Serum tube were centrifuged for 10 minutes 
at 2000g at room temperature. Each of the samples were then aliquoted into 4x1.5ml eppendorffs 
which were barcoded and logged onto RedCap as derivatives. These were all stored at -80oC and some 
of the samples, selected at random, were at a later stage delivered to UCT for analysis (see section 
2.2.1.11.). TBARS analysis was done on supernatant from centrifuged purple top EDTA samples and a 
phospholipid test on supernatant from the red top Serum tube. 
 
3.2.2.4 Blood Pressure Measurement 
 
Once in the exam room and explanations of the procedures were made participants were seated in 
an upright, relaxed position with the right arm supported at heart level and legs uncrossed. 
Confirmation that the participant was indeed fasted, had not smoked prior to the exam nor exercised 
or even climbed stairs in the 15-30min prior to the exam, was obtained. Participant was kept calm for 
at least 10 minutes. After properly fixing the cuff the OMRON M6 blood pressure monitor was used 
to record the blood pressure and heart rate measurements. Measurements were taken three times 
on the upper left arm with a 2-5 min interval between them. The systolic, diastolic pressures and heart 
rate was recorded.  
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3.2.3 Statistics 
 
The animal data was analyzed using GraphPad Prism 6 (GraphPad Software, San Diego, CA, USA) where 
the analysis of variance (ANOVA) was utilised for multiple comparisons testing. Post-hoc testing for 
differences between selected groups was determined by using Bonferroni’s method and a p-value of 
<0.05 was considered significant. 
 
A biostatistician at Stellenbosch University, Faculty of Medicine and Health Sciences, analysed the 
human data with SPSS. In the descriptive statistics normally distributed data were analysed using one-
way ANOVA and Bonferroni post hoc test was used to determine significant differences between 
groups. For categorical data Pearson’s Chi square analysis. Non-parametric data was analysed using a 
one way Kruskal-Wallis ANOVA which is a pairwise comparisons test. Forward stepwise regression 
analysis was conducted in order to determine independent predictors and associations between the 
groups. Normally distributed/ parametric data are expressed as mean ± standard deviation, non-
parametric data is expressed as median with 25th and 75th percentiles. 
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Chapter 4 – Results 
 
The results are listed in order according to the aims and the objectives of the study.  
 
4.1 Aim 1: Effects of Aspalathus linearis supplementation during first line fixed dose 
ART on isolated hearts and aortas of male Wistar rats.  
 
4.1.1 Body Weight Gained and Fluid Consumption 
 
Of particular interest in weighing the rats and measuring their fluid consumption weekly was to 
observe potential differences in these parameters between the groups. The average weight gained 
per group from commencement of treatment until day of sacrifice is depicted and the fluid 
consumption expressed as the average amount of fluid consumed by the group weekly. 
 
4.1.1.1  Body Weight Gained 
No significant differences were found in the average weight gained between the groups. Control: 
118.9±7.09 (g); Rooibos: 124.1±7.11 (g); ART: 108.4±7.72 (g); ART+Rooibos: 119±8.77 (g). N=22-25 
           
Fig. 4.1. Average weight gained/group during treatment period. Data expressed as mean ± 
SEM/group. 
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4.1.1.2 Fluid Consumption 
No differences were observed between groups in the average weekly fluid intake. Control: 
599.5±80.94 (ml/week); Rooibos: 620±88.17 (ml/week); ART: 598±60.09 (ml/week); ART+Rooibos: 
643.1±44.46 (ml/week). N=22-25 
            
Fig. 4.2. Average weekly fluid intake between groups. 
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4.1.2 Isolated Heart Perfusions 
 
In both the regional and global ischemia protocols the cardiac output (CO), aortic output (AO), 
coronary flow (CF), peak systolic pressure (PSP), diastolic pressure (DP), heart rate (HR) and total work 
(Wt) were the end points calculated and recorded during the period before the ischemic event, herein 
indicated by the term “baseline”, and after the ischemic event at reperfusion, indicated by the term 
“recovery”. Also illustrated below is the % AO recovery, % CO recovery and the % Wt recovery. These 
were calculated by dividing the recovery values by the baseline values and multiplying by 100. The end 
points were calculated at certain intervals of the protocols shown in fig. 3.2 and fig. 3.3 in section 
3.2.1.8. Baseline data for the global ischemia and regional ischemia were pooled to collectively 
investigate significant differences but because none were found all global and regional ischemia data 
are presented separately in this thesis. 
An additional end-point in the regional ischemia protocol is infarct size which is expressed as a 
percentage of the area at risk. 
 
4.1.2.1 Regional Ischemia 
 
Regional ischemia was established via occlusion of the left anterior descending coronary artery with a 
silk suture. This cessation of myocardial perfusion to the region surrounding the left coronary artery 
occurred for 35 min and a 60 min reperfusion period ensued thereafter. 
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4.1.2.1.1 AO 
No significant differences were observed in the baseline; recovery AO as well as the percentage AO 
recovery. AO baseline; Control: 42±4.07 (ml/min), ART: 36.86±1.84 (ml/min), Rooibos: 40±2.10 
(ml/min), ART+ Rooibos: 38.5±1.12 (ml/min). AO recovery; Control: 9.75±3.61 (ml/min), Rooibos: 
5±2.23 (ml/min), ART: 9.57±2.49 (ml/min), ART+ Rooibos: 13.75±3.88 (ml/min). AO recovery %; 
Control: 19.85±6.70 (ml/min), ART: 24.52±5.62 (ml/min), Rooibos: 11.53±4.80 (ml/min), ART+ 
Rooibos: 17.39±3.98 (ml/min). N=7-8 
 
Fig. 4.3. AO at baseline, recovery and the % recovery. (R.I). A. AO baseline. B. AO recovery. C. AO 
recovery % 
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4.1.2.1.2 CF 
CF did not differ between groups. A. CF baseline; Control: 16.63±0.78 (ml/min), Rooibos: 14.56±1.03 
(ml/min), ART: 16.29±0.52 (ml/min), ART+ Rooibos: 15.63±0.79 (ml/min). B. CF recovery; Control: 
13.31±2.91 (ml/min), Rooibos: 13.69±1.38 (ml/min), ART: 14.29±1.03 (ml/min), ART+ Rooibos: 
14.19±0.85 (ml/min). C. CF recovery %; Control: 78.86±17.31 (ml/min), Rooibos: 93.59±5.28 (ml/min), 
ART: 88.2±6.67 (ml/min), ART+ Rooibos: 92.6±7.12 (ml/min). N=7-8 
 
Fig. 4.4.  CF at baseline, recovery and as recovery %. (R.I). A. CF baseline. B. CF recovery. C. CF recovery 
% 
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4.1.2.1.3 CO 
CO did not differ between groups. A. CO baseline; Control: 58.63±3.87 (ml/min), Rooibos: 54.56±2.84 
(ml/min), ART: 53.14±2.22 (ml/min), ART+ Rooibos: 54.13±1.63 (ml/min). B. CO recovery; Control: 
23.06±5.83 (ml/min), Rooibos: 18.69±2.34 (ml/min), ART: 23.86±2.46 (ml/min), ART+ Rooibos: 
20.84±2.18 (ml/min). C. CO recovery %; Control: 36.61±8.60 (ml/min), ART: 38.81±7.13 (ml/min), 
Rooibos: 33.5±3.10 (ml/min), ART+ Rooibos: 38.97±4.21 (ml/min). N=7-8 
 
 
Fig. 4.5. Cardiac output at baseline, recovery and % cardiac output recovery. (R.I). A. CO baseline. B. 
CO recovery. C. CO recovery % 
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4.1.2.1.4 PSP 
No differences were observed, between groups, in the peak systolic pressure. A. PSP baseline; Control: 
92±2.14 (mmHg), Rooibos: 90.25±1.28 (mmHg), ART: 89.86±0.633 (mmHg), ART+ Rooibos: 90.38±1.15 
(mmHg). B. PSP recovery; Control: 61.13±13.44 (mmHg), Rooibos: 79.75±2.01 (mmHg), ART: 
82.14±0.46 (mmHg), ART+ Rooibos: 78.63±3.70 (mmHg). C. PSP recovery %; Control: 66.56±14.57 
(mmHg), Rooibos: 88.54±2.67 (mmHg), ART: 91.44±0.87 (mmHg), ART+ Rooibos: 87.2.±4.42 (mmHg). 
N=7-8 
 
 
Fig. 4.6. Peak systolic pressure at baseline, recovery and the recovery as a %. (R.I). A. PSP baseline. B. 
PSP recovery. C. PSP recovery % 
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4.1.2.1.5 DP 
DP showed no differences between groups. A. DP baseline; Control: 67.75±2.25 (mmHg), Rooibos: 
66±0.85 (mmHg), ART: 67.14±0.63 (mmHg), ART+ Rooibos: 66.5±1.03 (mmHg). B. DP recovery; 
Control: 49.75±10.91 (mmHg), Rooibos: 67.25±1.065 (mmHg), ART: 67.71±0.47 (mmHg), ART+ 
Rooibos: 65.88±2.57 (mmHg). C. DP recovery %; Control: 72.45±15.98 (mmHg), Rooibos: 101.9±1.3 
(mmHg), ART: 100.9.±0.65 (mmHg), ART+ Rooibos: 99.41±4.68 (mmHg). N=7-8 
 
 
Fig. 4.7. DP at baseline, recovery and % recovery. (R.I). A. DP baseline. B. DP recovery. C. DP recovery 
% 
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4.1.2.1.6 HR 
No differences were found in the HR pre and post ischemia. A. HR baseline; Control: 260.1±15.66 
(BPM), Rooibos: 270.9±8.31 (BPM), ART: 259.3±15.59 (BPM), ART+ Rooibos: 278±9.14 (BPM). B. HR 
recovery; Control: 206±47.89 (BPM), Rooibos: 258.6±6.35 (BPM), ART: 246.6±15 (BPM), ART+ Rooibos: 
264.6±11.39 (BPM). C. HR recovery %; Control: 75.28±16.88 (BPM), Rooibos: 95.68.6±1.56 (BPM), ART: 
96.01±5.82 (BPM), ART+ Rooibos: 95.31±3.06 (BPM). N=7-8 
 
 
Fig. 4.8. HR at baseline, recovery and % recovery. (R.I). A. HR baseline. B. HR recovery. C. HR recovery 
% 
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4.1.2.1.7 Wt 
Wt was similar between groups before and after ischemia and as a percentage of the recovery. A. Wt 
baseline; Control: 11.95±0.98 (mW), Rooibos: 10.88±0.68 (mW), ART: 10.52±0.48 (mW), ART+Rooibos: 
10.75±0.32 (mW). B. Wt recovery; Control: 4.19±1.10 (mW), Rooibos: 3.31±0.47 (mW), ART: 4.31±0.46 
(mW), ART+ Rooibos: 3.71±0.48 (mW). C. Wt recovery %; Control: 32.64±7.71 (mW), ART: 40.53±2.82 
(mW), Rooibos: 33.5±3.10 (mW), ART+ Rooibos: 35.03±4.42 (mW). N=7-8 
 
 
Fig. 4.9. Wt at baseline, recovery and % Wt recovery. (R.I). A. Wt baseline. B. Wt recovery. C. Wt 
recovery % 
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4.1.2.1.8 IS 
The ART group showed significantly greater % area of infarct than the control group (Control: 
28.17±5.10 (%AAR), ART: 50.56±4.08 (%AAR)). No significant differences were observed between the 
other groups. Control: 28.17±5.10 (%AAR), ART: 50.56±4.08 (%AAR), Rooibos: 39.37±5.83 (%AAR), 
ART+ Rooibos: 46.75±4.72 (%AAR). N=7-8  
                              
 
Fig. 4.10. IS expressed as a percentage of the area at risk (AAR).                                             
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4.1.2.2 Global Ischemia 
 
4.1.2.2.1 AO 
 
No significant differences were found in the AO baseline, recovery and percentage recovery between 
groups. A. AO baseline; Control: 37.78±1.87 (ml/min), Rooibos: 38±1.7 (ml/min), ART: 33±5.85 
(ml/min), ART+ Rooibos: 40.5±1.80 (ml/min). B. AO recovery; Control: 28.3±7.81 (ml/min), Rooibos: 
47.36±5.88 (ml/min), ART: 31.08±8.63 (ml/min), ART+ Rooibos: 32.63±8.82 (ml/min). C. AO recovery 
%; Control: 28.33±7.81 (ml/min), Rooibos: 47.36±5.88 (ml/min), ART: 31.08±8.63 (ml/min), ART+ 
Rooibos: 32.63±8.82 (ml/min). N=8-9 
 
Fig. 4.11. AO at baseline, recovery and the % recovery. (G.I). A. AO baseline. B. AO recovery. C. AO 
recovery % 
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4.1.2.2.2 CF 
A significant difference was found in the CF at baseline between the ART (11.63±0.91 (ml/min)) and 
ART+Rooibos (15.06±0.72 (ml/min)) group. No significant differences were observed between all 
other groups at recovery and the percentage recovery. A. CF baseline; Control: 13.94±0.77 (ml/min), 
Rooibos: 12.83±0.75 (ml/min), ART: 11.63±0.91 (ml/min), ART+ Rooibos: 15.06±0.72 (ml/min). B. CF 
recovery; Control: 12.06±0.52 (ml/min), Rooibos: 11.44±1.01 (ml/min), ART: 9±2.035 (ml/min), ART+ 
Rooibos: 11.75±1.33 (ml/min). C. CF recovery %; Control: 87.87±5.00 (ml/min), Rooibos: 89.56±6.28 
(ml/min), ART: 76.8±17.29 (ml/min), ART+ Rooibos: 78.51±7.96 (ml/min). N=8-9 
 
Fig. 4.12. CF at baseline, recovery and recovery as a %. (G.I). A. CF baseline. B. CF recovery. C. CF 
recovery % 
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4.1.2.2.3 CO 
 
CO at baseline, recovery and the % recovery did not differ significantly between groups. A. CO 
baseline; Control: 51.72±2.37 (ml/min), Rooibos: 50.83±2.26 (ml/min), ART: 44.63±6.61 (ml/min), 
Rooibos+ART: 55.56±2.10 (ml/min). B. CO recovery; Control: 22.94±3.22 (ml/min), Rooibos: 
30.11±3.79 (ml/min), ART: 21.44±5.51 (ml/min), Rooibos+ART: 25.5±4.46 (ml/min). C. CO recovery %; 
Control: 45.89±6.71 (ml/min), Rooibos: 57.87±5.43 (ml/min), ART: 44.8±10.3 (ml/min), ART+ Rooibos: 
45.35±7.48 (ml/min). N=8-9 
 
Fig. 4.13. Cardiac output at baseline, recovery and % cardiac output recovery. (G.I). A. CO baseline. B. 
CO recovery. C. CO recovery % 
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4.1.2.2.4 PSP 
PSP showed no significant differences between groups at baseline, recovery and recovery %. A. PSP 
baseline; Control: 88.44±0.58 (mmHg), Rooibos: 89.22±1.11 (mmHg), ART: 88.13±2.12 (mmHg), 
Rooibos+ART: 90.38±0.98 (mmHg). B. PSP recovery; Control: 80.89±2.32 (mmHg), Rooibos: 
84.78±1.33 (mmHg), ART: 71.71±12 (mmHg), ART+ Rooibos: 75.75±9.54 (mmHg). C. PSP recovery %; 
Control: 91.52±2.80 (mmHg), Rooibos: 95±0.60 (mmHg), ART: 69.98±15.31 (mmHg), ART+ Rooibos: 
83.75±10.42 (mmHg). N=8-9 
                       
 
Fig. 4.14. PSP at baseline, recovery and the recovery %. (G.I). A. PSP baseline. B. PSP recovery. C. PSP 
recovery % 
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4.1.2.2.5 DP 
No significant differences were found in the DP baseline, recovery and recovery % values between 
groups. A. DP baseline; Control: 65.56±0.80 (mmHg), Rooibos: 64.44±1.09 (mmHg), ART: 66.2±0.79 
(mmHg), Rooibos+ART: 65.13±0.91 (mmHg). B. DP recovery; Control: 64.78±2.07 (mmHg), Rooibos: 
66.33±0.96 (mmHg), ART: 49.75±10.93 (mmHg), Rooibos+ART: 58.63±8.39 (mmHg). C. DP recovery %; 
Control: 98.93±3.28 (mmHg), Rooibos: 103.2±2.31 (mmHg), ART: 75.36±16.5 (mmHg), Rooibos+ART: 
91.02±12.62 (mmHg). N=8-9 
      
 
Fig. 4.15. DP at baseline, recovery and recovery %. (G.I). A. DP baseline. B. DP recovery. C. DP recovery 
% 
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4.1.2.2.6 HR 
 
HR at baseline, recovery and the recovery % were not significantly different between groups. A. HR   
baseline; Control: 280.2±13.76 (BPM), Rooibos: 268.2±15.71 (BPM), ART: 237.9.3±5.81 (BPM), 
Rooibos+ART: 263.5±6.30 (BPM). B. HR recovery; Control: 260.8±8.67 (BPM), Rooibos: 229.3±11.57 
(BPM), ART: 187.8±41.69 (BPM), Rooibos+ART: 232.6±34.34 (BPM). C. HR recovery %; Control: 
94.27±4.30 (BPM), Rooibos: 87.01±4.90 (BPM), ART: 81.26±18.05 (BPM), Rooibos+ART: 88.44±12.93 
(BPM). N=8-9 
                       
 
Fig. 4.16. HR at baseline, recovery and recovery %. (G.I). A. HR baseline. B. HR recovery. C. HR recovery 
% 
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4.1.2.2.7 Wt 
There were no significant differences between groups in the Wt baseline, recovery and percentage 
recovery. A. Wt baseline; Control: 10.08±0.52 (mW), Rooibos: 10.01±0.54 (mW), ART: 8.85±1.45 
(mW), Rooibos+ART: 11.05±0.47 (mW). B. Wt recovery; Control: 4.17±0.66 (mW), Rooibos: 5.68±0.77 
(mW), ART: 3.98±1.04 (mW), Rooibos+ART: 4.76±0.97 (mW). C. Wt recovery %; Control: 41.54±6.47 
(mW), Rooibos: 55.17±5.36 (mW), ART: 41.96±9.77 (mW), Rooibos+ART: 41.99±7.91 (mW). N=8-9  
 
Fig. 4.17. Wt at baseline, recovery and % Wt recovery. (G.I). A. Wt baseline. B. Wt recovery. C. Wt 
recovery % 
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4.1.3 Vascular Reactivity Experiments  
 
The vascular reactivity experiments demonstrate the endothelial response to relaxation and 
contractility and are indicative of endothelial function. Significance was examined by a two-way 
ANOVA and determining the area under the curve (AUC) values.  
 
4.1.3.1 Vascular Reactivity Experiments without PVAT 
 
This first section depicts the vascular response to relaxation and contraction in the absence of 
perivascular adipose tissue (PVAT). 
 
4.1.3.1.1 Vascular response to acetylcholine (Ach): Cumulative relaxation 
The ART treated group relaxed significantly less than the ART+Rooibos treated group (p=0.003) and 
the control group (p=0.03). AUC: Control, 0.00094; Rooibos, 0.00093; ART, 0.00089; ART+Rooibos, 
0.00097. 
 
Fig. 4.18. Ach induced relaxation of the vasculature without PVAT. ART treated group relaxed 
significantly less than the ART+Rooibos (p=0.003) and the control (p=0.03) groups. N=20-25/group 
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4.1.3.1.2 Vascular response to phenylephrine (Phe): Cumulative contraction 
In the contraction response significant differences were observed between groups. The rooibos group 
contracted significantly more than the controls (p=0.0149), ART (p=0.0457) and ART+Rooibos groups 
(p=0.0468). AUC: Control, 53.26; Rooibos, 60.66; ART, 54.63; ART+Rooibos, 54.27. 
 
Fig. 4.19. Phe induced contraction of the vasculature without PVAT. Abbreviations; ART: antiretroviral 
therapy. The rooibos group contracted significantly more than the controls (p=0.0149), ART 
(p=0.0457) and the ART+Rooibos (p=0.0468). N=20-25/group 
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4.1.3.2 Vascular Reactivity Experiments with PVAT 
The following section depicts the contraction and relaxation responses of aortic rings in the presence 
of PVAT. 
 
4.1.3.2.1 Vascular response, with PVAT, to Ach: Cumulative relaxation 
In the presence of PVAT significant differences were found between the Control+PVAT group versus 
the Rooibos+PVAT group (p<0.0001), Control+PVAT versus ART+PVAT (p<0.01) and Control+PVAT 
versus Rooibos+ART+PVAT (p<0.01) in which case all of the treatment groups relaxed less than control. 
AUC: Control+PVAT, 0.00099; Rooibos+PVAT: 0.00079; ART+PVAT, 0.00091; ART+Rooibos+PVAT, 
0.00088. 
 
Fig. 4.20. Ach induced relaxation of the vasculature with PVAT. Abbreviations; PVAT: Perivascular 
adventitial tissue, ART: antiretroviral therapy. All treated groups relaxed significantly less than 
controls. Control+PVAT group versus the Rooibos+PVAT group (p<0.0001), Control+PVAT versus 
ART+PVAT (p<0.01) and Control+PVAT versus ART+Rooibos+PVAT (p<0.01). N=6-9/group 
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4.1.3.2.2 General effect of PVAT on Ach induced relaxation 
No significant differences were found in the relaxation between the rings with PVAT and the rings 
without PVAT. 
 
 
Fig. 4.21. General effect of PVAT on Ach induced relaxation. Abbreviations; ART: antiretroviral therapy. 
The presence of PVAT had no significant effect on Ach induced relaxation of the rings. A. Control 
+PVAT versus Control –PVAT. B. Rooibos +PVAT versus rooibos –PVAT. C. ART +PVAT versus ART –
PVAT. D. Rooibos +ART +PVAT versus Rooibos +ART –PVAT.  N=6-9/group 
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4.1.3.2.3 Vascular response, with PVAT, to Phe induced contraction: Cumulative contraction 
In the presence of PVAT, Phe induced contraction showed significant differences between the 
treatment groups. Rooibos+PVAT contracted significantly more than Control+PVAT (p<0.01), 
ART+PVAT group also contracted significantly more than the Control+PVAT group (p<0.05) and the 
combination treatment of ART+Rooibos+PVAT contracted significantly less than the Rooibos+PVAT 
group (p<0.05). AUC: Control+PVAT, 31.45; Rooibos+PVAT: 43.42; ART+PVAT, 36.32; 
ART+Rooibos+PVAT, 33.34. 
 
Fig. 4.22. Phe induced contraction of the vasculature with PVAT. Abbreviations; PVAT: Perivascular 
adventitial tissue, ART: antiretroviral therapy. Rooibos+PVAT and ART+PVAT contracted significantly 
more than Control+PVAT (p<0.01 and p<0.05 respectively). The combination treatment of 
ART+Rooibos+PVAT contracted significantly less than the Rooibos+PVAT group (p<0.05). N=6-9/group 
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4.1.3.2.4 General effect of PVAT on Phe induced contraction 
Significant differences were found in the contraction between aortic rings with PVAT and those 
without PVAT in all of the treatment groups. PVAT was anticontractile in all instances: Control +PVAT 
versus Control -PVAT group (p<0.0001); Rooibos +PVAT versus Rooibos -PVAT (p<0.0001). The ART 
+PVAT versus ART -PVAT (p<0.0001) had significant differences in contraction at all concentrations 
(100nM, 300nM, 500nM, 800nM and 1µM) of Phe (p<0.01 and p<0.001, where indicated) and Rooibos 
+ART +PVAT versus Rooibos +ART -PVAT (p<0.0001) with significant differences at 500nM, 800nM and 
1µM Phe concentrations. 
 
Fig. 4.23. General effect of PVAT on Phe induced contraction. Abbreviations; ART: antiretroviral 
therapy. The presence of PVAT significantly reduced Phe induced contraction in all groups. A. control 
+PVAT versus control -PVAT (p<0.0001). B. rooibos +PVAT versus rooibos -PVAT (p<0.0001). C. ART 
+PVAT versus ART -PVAT (p<0.0001) and p<0.01 at points 2,4,5,6 of Phe addition and p<0.001 at point 
3. D. rooibos +ART +PVAT versus rooibos +ART -PVAT (p<0.0001), p<0.01 at points 3, 4 and p<0.05 at 
point 5.  N=6-9/group 
Stellenbosch University  https://scholar.sun.ac.za
67 
 
4.1.4 Lipid profiles and TBARS levels 
The total cholesterol (TC); triglycerides (TG) and phospholipid (PL) levels are a representation of the 
lipid profiles and the TBARS levels an indicator of lipid peroxidation. A total of 22 samples were used 
for these analyses. 
 
4.1.4.1  Lipid profiles 
TC level in the rooibos group was significantly different to that of controls. TG and PL levels were not 
significantly different between the treatment groups. 
 
Fig. 4.24. Figure representing lipid levels. A. TC levels. Significant difference between rooibos and 
control (p=0.0481). Control:3.03±0.16 (mmol/L); Rooibos:2.48±0.05 (mmol/L); ART:2.67±0.13 
(mmol/L); ART+Rooibos: 2.61±0.16 (mmol/L). B. TG levels. Control:0.8±0.09 (mmol/L); 
Rooibos:0.99±0.26 (mmol/L); ART:0.61±0.08 (mmol/L);  ART+Rooibos:0.83±0.14 (mmol/L). C. PL 
levels. Control:1.57±0.07 (mmol/L); Rooibos:1.44±0.08 (mmol/L); ART:1.54±0.10 (mmol/L);  
ART+Rooibos:1.56±0.14 (mmol/L). N=5-6/ group 
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4.1.4.2 TBARS Levels 
No significant differences were found in the TBARS levels between the groups. 
 
Fig. 4.25. TBARS levels in μmol/L. No significant differences were found between groups. 
Control:7.69±0.55 (μmol/L); Rooibos:7.49±0.39 (μmol/L); ART:7.54±0.74 (μmol/L);  
ART+Rooibos:5.39±0.53 (μmol/L). N=5-6/group 
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4.2 Aim 2: Effects of rooibos tea consumption on the cardiovascular profiles of 
patients on first line fixed dose ART compared to controls 
 
4.2.1 Descriptive analyses of study population 
 
The study population comprising of 105 study participants from Durbanville, Fisantekraal, Elsies River, 
Uitsig, Bishop Lavis and Ravensmead consisted of 23 HIV negative, 14 HIV positive participants who 
were not on ART and 68 HIV positive who were on ART. The data is first described in Table 4.1 with 
the anthropometric data (ages, BMI, waist to hip ratio), cardiovascular outcomes and biochemical 
analyses (DP, SP, TC, HDL, LDL, TG, CRP and TBARS). Table 4.2 describes the population according to 
smokers versus non-smokers and Table 4.3 on the basis of gender. Percentage of participants who 
drank rooibos versus those who didn’t is described in Table 4.4. 
 
Table 4.1. Description of study population with parametric data expressed as mean ± standard 
deviation and CRP (non-parametric) expressed as median with 25th and 75th percentiles. 
n=105 HIV negative 
n=23 
HIV positive no 
ART    n=14 
HIV positive on ART     
n=68 
Outcomes/Variables Mean ± Standard Deviation 
Age 39.10±13.00 36.60±10.2 39.90±7.80 
BMI (kg/m2) 28.90±9.11 23.54±9.06 24.25±6.05 
Waist to hip ratio 0.91±0.084 0.86±0.07 0.87±0.81 
Diastolic Pressure 
(mmHg) 
93.80±15.20 80.10±8.90 83.50±9.90 
Systolic Pressure 
(mmHg) 
132.20±23.60 114.90±13.30 120.40±15.00 
Total Cholesterol 4.27±0.84 4.29±1.30 4.34±0.84 
HDL 1.23±0.39 1.22±0.51 1.30±0.39 
LDL 2.52±0.75 2.58±0.94 2.50±0.70 
Triglycerides 1.09±0.46 1.08±0.67 1.25±1.23 
TBARS 0.67±0.26 0.60±0.27 0.63±0.30 
 Median (Minimum;Maximum) 
CRP* 3.80(0.20;25.00) 2.05(0.20;59.70) 6.35(0.20;120.00) 
Abbreviations: HDL, high density lipoproteins; LDL, low density lipoproteins; TBARS, thiobarbituric acid reactive 
substances; CRP, C-reactive protein. *Non-parametric data expressed as median (minimum;maximum). 
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Table 4.2. Number of people in the study population that smoke versus non-smokers. 
 GROUP Total 
HIV 
negative 
HIV positive 
no ART 
HIV positive 
on ART 
smoke No Count 6 4 26 36 
     
Yes Count 17 10 42 69 
     
 
Table 4.3. Description of study population in terms of gender. 
 
GROUP 
Total HIV negative 
HIV positive no 
ART 
HIV positive on 
ART 
Gender  M Count 2 2 24 28 
% within group 8.7% 14.3% 35.3% 26.7% 
F Count 21 12 44 77 
% within group 91.3% 85.7% 64.7% 73.3% 
      
     
Abbreviations: M, Male; F, Female 
Table 4.4. Percentage of study population that drink rooibos. 
 HIV negative 
HIV positive 
no ART 
HIV positive 
on ART  
 Drink Rooibos? 
 0 = no 1 = yes 
0 Count 10 6 34 50 
% within group 43.5% 42.9% 50.7% 48.1% 
1 Count 13 8 33 54 
% within group 56.5% 57.1% 49.3% 51.9% 
Total Count 23 14 67 104 
% within group 100.0% 100.0% 100.0% 100.0% 
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4.2.2 Multiple comparisons test: one way ANOVA with Post Hoc test 
 
The multiple comparisons test, as represented in Table 4.2, compared the “(I) group” to the “(j) 
groups” of each variable. This revealed significant differences in the BMI, DP and SP levels. The HIV 
negative group (28.90±9.11 (kg/m2)) had a significantly higher BMI compared to the HIV positive no 
ART (23.54±9.06 (kg/m2)) group. Blood pressure (DP and SP) was significantly higher in the HIV 
negative group (93.80±15.20 (mmHg)) compared to the HIV positive no ART (10.327±2.689 (mmHg)) 
and HIV positive on ART (83.50±9.90 (mmHg)).    
 
Table 4.5. Results of multiple comparisons analysis- One way ANOVA. 
Dependent 
Variable (I) group (J) groups Sig. 
 
Mean Difference(confidence interval) 
Age HIV negative HIV positive no 
ART 
1.00 
2.49(-5.33;10.31) 
HIV positive on 
ART 
1.00 
-0.72(-6.29;4.84) 
HIV positive no 
ART 
HIV negative 1.00 -2.49(-10.31;5.33) 
HIV positive on 
ART 
.75 
 
-3.21(-9.98;3.56) 
BMI HIV negative HIV positive no 
ART 
.09 
5.36(-0.62;11.33) 
HIV positive on 
ART 
.027 
4.65(0.40;8.90) 
HIV positive no 
ART 
HIV negative .09 -5.36(-11.33;0.61) 
HIV positive on 
ART 
1.00 
 
-0.71(-5.88;4.46) 
Wasit to hip ratio HIV negative HIV positive no 
ART 
.23 
0.05(-0.02;0.11) 
HIV positive on 
ART 
.08 
 
0.04(-0.00;0.09) 
HIV positive no 
ART 
HIV negative .23 -0.05(-0.11;0.02) 
HIV positive on 
ART 
1.00 
 
-0.00(-0.06;0.05) 
DP HIV negative HIV positive no 
ART 
.001 
13.71(4.51;22.91) 
HIV positive on 
ART 
.001 
 
10.33(3.78;16.87) 
HIV positive no 
ART 
HIV negative .001 -13.71(-22.91;-4.51) 
HIV positive on 
ART 
.91 
 
-3.38(-11.35;4.58) 
SP HIV negative HIV positive no 
ART 
.01 
17.29(3.24;31.33) 
HIV positive on 
ART 
.01 
 
11.82(1.83;21.81) 
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HIV positive no 
ART 
HIV negative .01 -17.29(-31.33;-3.24) 
HIV positive on 
ART 
.83 
 
-5.47(-17.63;6.67) 
Total cholesterol HIV negative HIV positive no 
ART 
1.00 
-0.02(-0.78;0.74) 
HIV positive on 
ART 
1.00 
 
-0.07(-0.62;0.47) 
HIV positive no 
ART 
HIV negative 1.00 -0.02(-0.74;0.78 
HIV positive on 
ART 
1.00 
 
-0.05(-0.71;0.60) 
HDL HIV negative HIV positive no 
ART 
1.00 
0.01(-0.33;0.35) 
HIV positive on 
ART 
1.00 
 
-0.07(-0.32;0.17) 
HIV positive no 
ART 
HIV negative 1.00 -0.01(-0.35;0.33) 
HIV positive on 
ART 
1.00 
 
-0.09(-0.38;0.20) 
LDL HIV negative HIV positive no 
ART 
1.00 
-0.06(-0.68;0.56) 
HIV positive on 
ART 
1.00 
 
0.02(-0.42;0.47) 
HIV positive no 
ART 
HIV negative 1.00 0.06(-0.56;0.68) 
HIV positive on 
ART 
1.00 
 
0.08(-0.45;0.62) 
Triglycerides HIV negative HIV positive no 
ART 
1.00 
0.01(-0.86;0.89) 
HIV positive on 
ART 
1.00 
 
-0.16(-0.79;0.47) 
HIV positive no 
ART 
HIV negative 1.00 -0.01(-0.89;0.86) 
HIV positive on 
ART 
1.00 
 
-0.17(-0.92;0.58) 
CRP HIV negative HIV positive no 
ART 
1.00 
-5.59(-20.03;8.84) 
HIV positive on 
ART 
.49 
 
-5.90(-16.18;4.37) 
HIV positive no 
ART 
HIV negative 1.00 5.59(-8.84;20.03) 
HIV positive on 
ART 
1.00 
 
-0.04(-0.18;0.26) 
TBARS 
µmol/mmol 
HIV negative HIV positive no 
ART 
1.00 
0.07(-0.23;0.37) 
HIV positive on 
ART 
1.00 
 
0.04(-0.18;0.26) 
HIV positive no 
ART 
HIV negative 1.00 -0.07(-0.37;0.23) 
HIV positive on 
ART 
1.00 
 
-0.03(-0.18;0.26) 
Bold results indicate statistically significant results (P value <0.05) 
Abbreviations: DP, diastolic pressure; SP, systolic pressure; HDL, high density lipoproteins; LDL, low density 
lipoproteins; CRP, C-reactive protein; TBARS, thiobarbituric acid reactive substances 
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4.2.3 Regression analysis to determine effects of drinking rooibos 
So as to determine the effects of rooibos in the presence and absence of ART, regression analysis was 
conducted only on HIV positive participants. The results therefore compare the groups no Rooibos on 
ART, Rooibos no ART and Rooibos on ART, relatively to the baseline group of no Rooibos no ART. The 
outcomes/dependent variables analysed were: DP, SP, HDL, LDL, Trigs, TC, CRP and TBARS. ART status 
and rooibos drinking were considered as independent variables and BMI, waist to hip ratio, age, 
gender and smoking were all controlled for. No significance was found in any of the comparisons. 
 
Table 4.6. Regression analysis on rooibos drinking data. 
 No Rooibos no ART Rooibos no ART Rooibos on ART 
Outcomes β 
coefficient(confidence 
interval) 
P 
value 
β 
coefficient(confidence 
interval) 
P 
value 
β 
coefficient(confidence 
interval) 
P 
value 
DP -1.55(-10.06,6.97) 0.72 -6.93(-17.43,3.56) 0.19 0.05(-17.43, 3.56) 0.99 
SP -3.02(-14.85, 8.81) 0.61     -8.46(-23.04, 6.12) 0.25    -0.85(-12.68, 10.99) 0.89 
TC -0.31(-1.11, 0.49) 0.44 -0.89(-1.88, 0.10) 0.08 -0.73(-1.54, 0.07) 0.07 
HDL -0.10(-0.47, 0.28) 0.60 -0.35(-0.81, 0.11) 0.13 -0.11(-0.48, 0.27) 0.57 
LDL -0.26(-0.94, 0.42) 0.44 -0.52(-1.38, 0.34) 0.23 -0.60(-1.29, 0.08) 0.08 
TG 0.42(-0.55, 1.40) 0.38 0.50(-0.73, 1.74) 0.42 0.18(-0.81, 1.16) 0.72 
TBARS -0.03(-0.40, 0.32) 0.83 -0.18(-0.62, 0.25) 0.40 -0.14(-0.49,0.21) 0.44 
CRP 0.40(-0.17, 0.98) 0.16 0.25(-0.48, 0.98) 0.50 0.43(-0.15,1.01) 0.15 
Abbreviations: DP, diastolic pressure; SP, systolic pressure; TC, total cholesterol; HDL, high density lipoproteins; 
LDL, low density lipoproteins; CRP, C-reactive protein; TBARS, thiobarbituric acid reactive substances 
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Chapter 5 – Discussion 
 
5.1 Effects of Aspalathus linearis supplementation during ART on isolated hearts 
and aortas of male Wistar rats.  
 
In order to avoid repetition and promote congruency the BMI, lipid profile and TBARS results of the 
human study are also discussed in this section, below the respective titles. Section 5.2 “Effects of 
rooibos consumption on the cardiovascular profiles of patients on ART” contains the discussion of all 
other findings of the epidemiological study starting with a description of the study population and 
ending with the effects of drinking rooibos. 
  
5.1.1 Body Weights and Fluid Consumption 
 
The body weight gained over the 9 week treatment period and the weekly fluid intake did not differ 
significantly between the groups. Thus the ART, rooibos and combination had no significant effect on 
the weights and fluid consumption of the rats. In the epidemiological aspect of the present study the 
HIV negative group had a significantly higher BMI (28.90±9.11 (kg/m2)) compared to the HIV positive 
on ART (24.25±6.05 kg/m2) group. Extensively described in literature are the metabolic effects of 
HAART. The reported metabolic effects of the efavirenz/emtricitabine/tenofovir single dose 
formulation are not very consistent. Some studies have found no changes in body weight, body mass 
index (BMI) and whole body fat after a switch from a previous ART combination to the once-daily fixed 
dose efavirenz/emtricitabine/tenofovir combination (Deeks & Perry 2010). An earlier study conducted 
during 1997-2000 specifically looked at the body composition of 224 antiretroviral-naïve and 
antiretroviral-experienced human participants. The study found median increases in body weight and 
lean body mass (LBM) occurred after 16 weeks of therapy but significantly greater median increases 
in body weights was found in individuals who had achieved virological suppression. Participants who 
were antiretroviral naïve at baseline gained more weight and LBM after 16 weeks of treatment than 
participants who were previously on ART. (Shikuma et al. 2004) 
 
The study by Akinboro et al. investigated the effects of first line HAART on body weight and 
demonstrated that HAART represses weight loss along with CD4 cell depletion. They examined the 
body weights of newly diagnosed HIV patients upon diagnosis and 48 weeks post HAART and found a 
significant increase in the mean body weight post HAART. It is important to note, however, that these 
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are results obtained within the context of HIV, that is, in a pathological condition. These results 
therefore support and explain the epidemiological findings of the present study, where HIV infection 
without ART inevitably induces weight loss. HIV without HAART has been found to decrease body 
weight by inducing oxidative stress which activates NF-κB leading to apoptosis of T-lymphocytes and 
increased HIV replication. HAART induces viral suppression and in this way also suppresses weight 
loss- hence the observed changes in weight once HAART is commenced. (Akinboro et al. 2013)  
 
One could, therefore, reason that in the absence of HIV, as in the context of the animal part of this 
study, the previously observed effects of HAART on body weight would be nonexistent. Another 
possible reason for ART having no effect on body weight in the present study could be the duration of 
the treatment period. Perhaps with a treatment period that is considerably longer than 9 weeks one 
would observe significant differences in body weights. 
 
Rooibos infusion having no significant effect on body weight and fluid consumption is not a novel 
finding (Katengua-Thamahane et al. 2014). When investigating the anti-inflammatory effects of 
rooibos infusion in rats, Baba et al. treated two groups for four weeks. One was the control group, 
that received water to drink and the other was given unfermented rooibos infusion. After four weeks 
of treatment no significant differences were found in the body weight gained, appetite or fluid 
consumption between the groups (Baba et al. 2009). Another study that tested the ability of an 
aqueous fermented rooibos extract to ameliorate lipopolysaccharide-induced liver injury also treated 
rats with the infusion for 4 weeks (Ajuwon et al. 2014). They found no significant differences in body 
weight gained and fluid consumption between the groups (Ajuwon et al. 2014).  
 
The results of a few studies performed on cell cultures, animals and human studies suggest that 
dietary polyphenols have the potential to facilitate weight loss or inhibit weight gain (Meydani & 
Hasan 2010). These studies, however, investigated only specific polyphenols none of which being the 
ones that are predominantly found in rooibos infusion, that is, aspalathin and nothofagin (Meydani & 
Hasan 2010). Polyphenol rich foods remain a dietary recommendation especially for preserving an 
ideal body weight (Meydani & Hasan 2010). 
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5.1.2 Isolated Heart Perfusions: Functional Recovery and Infarct Size (IS) 
 
The results of the global and regional ischemia protocols showed no significant differences between 
groups in all examined end points except IS and coronary flow (CF) at baseline in the global ischemia 
protocol. IS was significantly increased in the ART treated group compared to the controls and the 
ART+Rooibos treated group had a significantly increased CF at baseline compared to the ART group. It 
was observed that the AO and CO at recovery and the respective recovery percentages of the rooibos 
treated group had lower output values in the regional ischemia protocol but higher output values in 
the global ischemia protocol compared to the control, ART and combination groups. These were, 
however, not significant. The effects of rooibos infusion on cardiovascular function in a perfusion 
setting have not been well explored thus studies pertaining to this topic are very limited.  
 
A 2011 publication by Pantsi et al. investigated the ability of rooibos to offer cardiac protection against 
ischemia reperfusion injury. In this study male Wistar rats received rooibos (fermented or 
unfermented) or water to drink and standard rat chow (SRC) for 7 weeks. The concentration of rooibos 
used was a 2% (w/v) infusion. The investigators documented mechanical function by measuring the 
AO before and after a 15 minute global ischemia insult. AO recovery was the only functional parameter 
measured. Groups that were treated with rooibos (fermented and unfermented) had significantly 
increased AO recoveries compared to controls. (Pantsi et al. 2011) 
 
Another study investigated the anti-inflammatory effects of red palm oil and rooibos on rats. The rats 
were divided into different treatment groups and received either a 2% (w/v) rooibos formulation, red 
palm oil or the combination for 4 weeks and there after certain groups were given a lipopolysaccharide 
(LPS) injection 18 hours before sacrifice in order to induce acute systemic inflammation. The hearts 
were mounted and perfused on the Langendorff system for 15minutes. The parameters measured 
were, amongst others, coronary flow (CF), heart rate (HR), left ventricular developed pressure 
(LVDevP) and end diastolic left ventricular pressure (EDLVP). The authors observed no significant 
differences in any of these cardiac function parameters. (Katengua-Thamahane et al. 2014) 
 
The differences between these two studies and the present study are worth mentioning. Although 
Katengua-Thamahane et al. found no significant differences at baseline in cardiac function parameters 
their perfusion protocol consisted solely of Langendorff perfusion and no ischemia was induced, 
furthermore, the treatment period was significantly shorter. The study by Pantsi et al. had a more 
similar perfusion protocol and treatment period but found significant differences in the AO. The lack 
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of significant differences in cardiac parameters between groups in the present study, when compared 
to that of Pantsi et al, could be due to a longer ischemic event in this study which could have caused 
increased post-ischemic contractile abnormalities and thus reduced contractile performance at 
recovery (Bolli & Marban 1999). This phenomenon is termed myocardial stunning (Bolli & Marban 
1999). 
 
IS was significantly increased in the ART group compared to the control whereas this significant 
increase in IS was not observed in the rooibos nor the Rooibos+ART treated groups when compared 
to controls. These results indicate that ART could cause decreased cell viability. The possible 
mechanism by which this single dose ART formulation could have resulted in increased IS is through 
its effects on ER stress. EFV has been demonstrated to induce ER stress and ER stress induced 
apoptosis and therefore decreased cell viability- section 2.4.4 “Mechanism of ART Induced CVD” 
(Bergin et al. 2015). The effect of ART on IS is a novel finding and suggests that the mechanism by 
which this FDC causes CVD is through ER stress induced apoptosis. 
 
Treatment with rooibos showed no change in IS when compared to control. Rooibos infusion as a 
potent antioxidant should theoretically be able to increase an organism’s antioxidant capacity. One of 
the known causes and, simultaneously, an effect of ER stress is oxidative stress. In ameliorating the 
anti-oxidant capacity, supplementation with rooibos should result in a decrease in oxidative stress and 
thus downstream alleviation of inflammation and endothelial dysfunction. This effect was, however, 
not observed.  
 
Supplementation of ART treated rats with rooibos did not show the significantly increased IS above 
control that ART treatment alone displayed, in fact the IS in the ART + Rooibos group was no different 
to control values. While the difference in IS between ART (50.56±4.08 (%AAR)) and ART + Rooibos 
(46.75±4.72 (%AAR)) was not significant, perhaps having pro-longed the treatment period, increased 
the rooibos infusion concentration or even orally administered set quantities of the rooibos could 
have translated to significant effects on cell viability.  
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5.1.3 Vascular Reactivity Studies 
 
5.1.3.1 Endothelial Response without PVAT 
 
The aortic ring studies demonstrated that ART significantly reduced Ach induced relaxation compared 
to both the control and the Rooibos + ART treated groups. The downstream effects of ER stress are 
increased oxidative stress leading to endothelial dysfunction and reduced NO bioavailability (Fig 2.5). 
The significant reduction in relaxation in the ART treated group is a clear indication of impaired 
endothelial function which may be attributed to ER stress signaling or ROS. Supplementation with 
rooibos infusion effectively changed this outcome causing the combination treated group (Rooibos + 
ART) to relax similarly to the control group and significantly more than the ART group.  
 
The body of laboratory studies that have investigated the direct links of ART on the endothelium are 
sparse.  A 2006 publication report investigated effects of azidothymidine (AZT), an NRTI, and indinavir, 
a PI, on endothelial function. They treated male Sprague-Dawley rats with clinically relevant doses of 
AZT, indinavir or the combination for 30 days through their drinking water. Endothelial function was 
assessed through isometric force measurements in aortic rings. Results showed that endothelial 
relaxation was dramatically reduced in AZT and AZT + indinavir treated rats. Surprisingly, indinavir 
treatment alone showed no effects on endothelial function (Jiang et al. 2006). AZT, like emtricitabine 
and tenofovir, is a NRTI and thus have the same mechanism of action. 
 
Scientific studies have begun to unravel the mechanisms by which flavonoids induce vasodilation apart 
from scavenging ROS, promoting proper endothelial functioning and thus indirectly promoting 
vasodilation. The proposed direct mechanisms are through opening of potassium (K+) channels and 
inhibition of vascular calcium current (Scholz et al. 2010; Gilani et al. 2006). In vascular smooth muscle 
cells contraction is achieved when the cell membrane is depolarized through an influx of calcium (Ca2+) 
stimulating the release of calcium from intracellular stores (Consigny 1991). Flavonoids are proposed 
to induce relaxation by activating the enzyme adenylate cyclase (AC) or guanylate cyclase (GC) 
resulting in the elevation of cyclic adenosine monophosphate (cAMP) or cyclic guanosine 
monophosphate (cGMP) respectively (Consigny 1991; Ledoux et al. 2006). Once these are activated 
either nucleotide can cause the opening of potassium channels leading to K+ efflux, repolarization of 
the membrane and consequently relaxation (Consigny 1991).  Gilani et al, through their work on rabbit 
jejunum, have shown that the vasodilatory effects of rooibos could be due to an interplay of K+ channel 
activators and low level Ca2+ antagonistic activity (Gilani et al. 2006).  
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The rooibos treatment did not significantly affect relaxation compared to the other groups and 
interestingly this treatment, in the absence of ART, resulted in increased contraction compared to all 
the other treatment groups. There is evidence to suggest that polyphenol supplementation, in high or 
excessive dose, is detrimental to the health (Martin 2009). The plausible mechanism behind this 
deleterious effect lies in the ability of phenolic antioxidants to auto-oxidate and thus behave like pro-
oxidants at high concentrations (Martin 2009). Villanueva and Kross in the review “Antioxidant-
induced stress” present the hypothesis that an excessive amount of antioxidants can overwhelm the 
body’s free radicals, disrupting the endogenous balance between antioxidants and reactive species 
thus giving rise to antioxidant-induced stress (Bouayed & Bohn 2010; Villanueva & Kross 2012). The 
review cites a number of studies that have found antioxidant supplementation to have harmful effects 
(Albanes et al. 1996; Challem 1997; Cheung et al. 2001; Villanueva & Kross 2012). The results of the 
present study propose that rooibos supplementation is beneficial under certain stress conditions 
whereas under normal physiological conditions it could lead to certain abnormalities.  
 
The studies on antioxidant supplementation have focused solely on the ingestion of antioxidants in 
the form of supplements and not as a food source, unlike the present study. Ingesting antioxidants 
from natural sources, as in rooibos, allows for synergistic activity by the anti-oxidants, limiting their 
chance of auto-oxidating and consequently resulting in more beneficial effects (Villanueva & Kross 
2012). However, the fact that an excessive amount of antioxidants not only has the potential of auto-
oxidating but can also overwhelm the body’s free radicals might explain the surprising results in the 
rooibos treated group. Although not given in the form of a supplement, the rooibos infusion was the 
only fluid this particular group had to drink. In the absence of a pathological condition, this may have 
overwhelmed the body’s essential basal level of free radicals thus causing abnormalities or more 
specifically speaking, increased contractile response of the aorta.  
  
No studies could be found that investigated possible toxicity of rooibos ingestion in the clinical or 
laboratory setting. Determining the quantities or upper limit that may be detrimental to a healthy 
person is, therefore, of utmost significance. 
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5.1.3.2  Endothelial Response with PVAT: Effect of PVAT 
 
Whilst no considerable effect was found of the PVAT surrounding the aorta on ach induced relaxation, 
contraction graphs showed that PVAT considerably decreased contraction in all treatment groups. An 
investigation by Lee et al. (2014) sought to determine the mechanism by which PVAT regulates 
vascular tone by conducting isometric tension studies on isolated thoracic aortas from Wistar rats. 
The study used adult rats that had free access to water and standard rat chow (Lee et al. 2014). Unlike 
the present study their results revealed that PVAT significantly increases vasoconstriction and inhibits 
vasodilation (Lee et al. 2014). Through western blot analyses they were able to conclude that this 
resulted from decreased aortic NO production without any effect on the expression and activity of 
eNOS (Lee et al. 2014).  These authors were able to prove that PVAT induced contractility of the 
vasculature results from PVAT causing over expression of caveolin-1 (CAV-1). CAV-1 is a negative 
regulator of eNOS and may have been a key role player in the PVAT elicited contractility observed in 
the present study. 
 
Some studies have however, provided evidence that PVAT exerts anti-contractile effects by releasing 
an endothelium dependent relaxing factor (Gao et al. 2009). Also termed adipocyte-derived relaxing 
factor (ADRF), this factor has been proven to cause relaxation of the vasculature by activating K+ 
channels found in vascular smooth muscle cells (VSMC) (Rajsheker et al. 2010). In contrast, other 
studies have found the pro-contractile effect of PVAT to be related to an obese phenotype either via 
oxidative stress (Ketonen et al. 2010) or obesity induced alterations in the PVAT proteome (Owen et 
al. 2013). Because the results of the present study showed decreased contractility for all groups with 
PVAT, it would appear that PVAT elicits anti-contractile effects irrespective of the phenotype. The 
discrepancies between the results of the present study and studies that have proven pro-contractile 
effects can be explained by PVAT’S ability to elicit both relaxation and contraction of the vasculature 
(Brown et al. 2014). Also, a key point to remember is that the rats in the present study were not obese. 
The exact conditions under which these effects are manifested have yet to be fully elucidated. 
 
5.1.4 Biochemical Analyses 
 
5.1.4.1  Lipids 
 
In the animal study no significant differences were found in the phospholipid (PL) and triglyceride 
levels between groups but total cholesterol (TC) levels decreased significantly in the rooibos treated 
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group compared to the control group. The human study showed no significant differences in lipid 
profiles between the groups. A study conducted at the Cape Peninsula University of Technology 
(CPUT) tested the effects of different concentrations of rooibos extract on lipid profiles, antioxidant 
status, and liver histopathology in male Wistar rats that had been orally administered the extract. A 
2, 4 and 6% aqueous rooibos extracts were administered orally for 7 weeks. The authors found no 
significant differences in lipid profiles between the groups and rooibos in all concentrations led to 
improved antioxidant capacity. (Ayeleso et al. 2013) 
 
Several studies do, however, support the lipid and particularly cholesterol lowering ability of dietary 
polyphenols in health and disease state (Marnewick et al. 2011; Bahadoran et al. 2013; Zanotti et al. 
2015). One such study entailed hyperlipemic and control male mice being given free access to either 
rooibos (10g/l), or water and food for 14 weeks (Beltrán-Debón et al. 2011). The treatment resulted 
in significant reductions in serum cholesterol and TRIG levels but only in the hyperlipemic mice and 
no effects were observed in the control mice, that is, the mice without metabolic disturbances 
(Beltrán-Debón et al. 2011). In a small epidemiological study rooibos consumption was found to 
decrease LDL-cholesterol and TRIG levels whilst increasing HDL- cholesterol (Marnewick et al. 2011). 
The study involved a cohort of 40 volunteers who were at risk for cardiovascular disease (Marnewick 
et al. 2011). The volunteers drank 6 cups of traditional fermented rooibos daily for 6 weeks. Thus the 
controversy surrounding the effects of dietary polyphenols on lipid metabolism studies have 
evidenced the cholesterol lowering ability of dietary polyphenols to result from inhibition of 
cholesterol synthesis (Zanotti et al. 2015).  
 
The lack of significant findings in the present study comparative to the epidemiological study by 
Marnewick et al could be mainly due to the different natures of the two studies. The present study 
was an observational study and relied on the accurate reporting of rooibos consumption by the 
participants. The current study might have observed differences had a set amount of rooibos been 
given to a certain group as an intervention for a pre-determined period of time.  
 
The results in the ART group were not as expected. In the present study ART had no significant effects 
on the lipid profiles of the rats whereas it is well established that ART causes dyslipidemia in the long 
term (Valle et al. 2013; Nduka et al. 2015). The absence of significant differences in the lipid profiles 
of the patients in the human study was also surprising. Studies have found patients on ART, particularly 
the broad spectrum of HAART including PI’s, to have significantly higher total cholesterol levels and 
triglycerides compared with HIV positive ART naïve patients (Valle et al. 2013; Nduka et al. 2015). A 
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study conducted in America investigating certain effects of HIV disease in an ART-naïve cohort found 
advanced HIV disease to be associated with decreased HDL and LDL cholesterol. The study population 
consisted of 419 patients of which the average age was 38.2 years (El-Sadr et al. 2005).  
 
A little closer to SA, a cross-sectional study conducted in Cameroon between November 2009 and 
January 2010 investigated the lipid profiles of 138 HIV positive ART-naïve patients and 138 HIV positive 
patients who were on first line NNRTI based ART regimens (Pefura Yone et al. 2011). The study found 
the NNRTI based ART regimen to be significantly and positively associated with raised TC and LDL-
cholesterol (Pefura Yone et al. 2011). A more recent study has investigated the prevalence of 
dyslipidemia in HIV infected patients in South Africa. Once again the two groups were HIV infected 
ART naïve patients (406 patients) and HIV infected receiving either a NNRTI- based regimen or a PI- 
based regimen (551 patients) (Dave et al. 2016). The study found patients on ART to have significantly 
higher TRIG, TC, LDL-cholesterol and HDL- cholesterol, than the ART naïve patients, irrespective of the 
ART regimen (Dave et al. 2016). Interestingly, although these levels were significantly increased 
compared to the ART naïve patients, levels of lipid abnormalities requiring evaluation and treatment 
were uncommon (Dave et al. 2016). Most studies have found PI’s to be associated with remarkable 
dyslipidemia and NNRTI’s to improve plasma lipid levels (Fisher et al. 2006). Taking this fact into 
account, the fact that the present study is one of the first to investigate not only this specific FDC but 
to further do so on a SA cohort and the limited number of participants recruited for the study sheds 
some understanding as to the lack of similarity to findings of other studies. Furthermore, the absence 
of a significant difference in lipids between ART naïve and ART compliant individuals may be reflective 
of a possible positive aspect of the current FDC. 
 
Whereas the studies that have found significant results investigated population sizes with an n-value 
of no less than 400. The present study had a population size of 105 participants which was further 
sub-divided into HIV negative, n=23; HIV positive no ART, n=14 and HIV positive on ART, n=68. The 
sample size of the present study was, thus, considerably smaller. Perhaps with a longer period of ART 
the present study may have found significant changes in the lipid profiles of the ART group in the 
animal study.  
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5.1.4.2  TBARS 
 
Surprisingly in both the animal and human study, no significant differences were evidenced in the 
TBARS levels between the groups. As TBARS level is a marker of lipid peroxidation and ROS indicator 
it can thus be used as an indirect marker of antioxidant capacity. Ideally we expected to observe, in 
the animal study, a significant increase in TBARS levels in the ART group compared to all the other 
groups and reduced TBARS levels in the rooibos and Rooibos + ART treated groups. Scientific reports 
that have investigated ART induced toxicity have found different ART combinations to significantly 
reduce antioxidants and antioxidant capacity while causing an increase in lipid oxidation and oxidative 
damage (Valle et al. 2013).  
 
The novelty of this study and furthermore the novelty of these results, although not significant, 
provides insight on the effects of the efavirenz/emtricitabine/tenofovir FDC. We can deduce from 
these results that this specific FDC possibly does not cause ROS as extensively as other previously 
investigated combinations or that it would need a longer period than 9 weeks to cause observable 
changes in lipid peroxidation or antioxidant levels. 
 
A number of studies have demonstrated an improved anti-oxidant capacity in rats supplemented with 
fermented rooibos extracts for up to 10 weeks (Marnewick et al. 2003; Kucharská et al. 2004; Ajuwon 
et al. 2013). Furthermore, several studies have confirmed the antioxidant and lipid peroxidation 
inhibiting properties of rooibos (Standley et al. 2001; Krafczyk et al. 2009; Ajuwon et al. 2015). The 
proposed mechanism by which rooibos polyphenols improve oxidative status is through direct 
scavenging of ROS and free radicals (Steenkamp et al. 2004; Ajuwon et al. 2015). The above mentioned 
studies that have examined the antioxidant and lipid peroxidation inhibiting properties of rooibos, 
have used more than one technique to determine the level of lipid peroxidation and or anti-oxidant 
capacity. Perhaps therein lies a possible short fall in the present study, for both the animal and the 
human aspect, which resulted from monetary constraints. Significant differences in lipid peroxidation 
products and anti-oxidant capacity between groups may have been observed had we complemented 
the TBARS test with a test for conjugated dienes or total antioxidant capacity (TAC). 
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5.2 Effects of rooibos consumption on the cardiovascular profiles of patients on 
ART.  
 
Of the 105 study participants there were 23 HIV negative, 14 HIV positive who were not on ART and 
68 HIV positive who were on ART. Females accounted for 73% (n=77) of the population. 65% percent 
of the population were smokers and 51.9% indicated that they drink rooibos tea. The average age of 
the total population was 39.3 years. 
 
Multiple comparisons test on the whole population revealed significant differences in blood pressure 
(BP) and no differences in the CRP levels between groups. The HIV negative patients were found to 
have significantly higher BP (DP and SP) than the HIV positive no ART and the HIV positive on ART. 
Literature on the effects of HIV and ART on BP is somewhat controversial. A relatively small British 
study that investigated the effect of ART on BP in 95 patients who were previously ART naïve found 
the BP levels to increase significantly after 48 weeks of ART (Palacios et al. 2006).  
 
A larger cross-sectional survey conducted on a population of 612 adults aimed to determine the 
associations between BP, HIV status and ART with and without NNRTI’s (Wilson et al. 2009). The study 
found NNRTI’s to be associated with increased BP (Wilson et al. 2009). These studies were, however, 
conducted in Britain where the population is considerably different to South Africa’s mixed ancestry 
and lower socio economic population (Western Cape Government 2015). Data on the effects of HIV 
and ART on SBP in SA can be found in at least one study conducted in Kwazulu-Natal (Feigl et al. 2016). 
The study evaluated the SBP of 505 individuals in the groups HIV negative, seroconverters, HIV positive 
not on ART and HIV positive on ART (Feigl et al. 2016). SBP readings were taken in 2003 and in 2010 
and it was found that SBP dropped significantly in the HIV positive no ART group and in the HIV 
positive+ ART group (Feigl et al. 2016). These decreases were further investigated relative to the HIV 
negative group and were found to still be significant (Feigl et al. 2016). Similar results were obtained 
in an earlier Sub-Saharan Africa study of the association of HIV and ART with cardiometabolic traits 
where HIV was found to be associated with decreased BP (Dillon et al. 2013). 
 
Regression analysis on consumption of rooibos showed no significant differences in BP, lipid profiles, 
CRP and TBARS between patients who indicated to be rooibos drinkers and those who didn’t. In 
scientific investigations tea polyphenols, and specifically rooibos has been established to lower BP via 
inhibition of the angiotensin converting enzyme (ACE) (Persson et al. 2006; Persson 2012). These 
investigations were conducted in vitro on endothelial cells from human umbilical veins (HUVEC’s) and 
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on incubated serum of healthy volunteers (Persson et al. 2006; Persson 2012). The present study 
differs in that it examined possible effects of rooibos drinking on BP in vivo. Moreover, participants 
possibly were not consistent in drinking the tea daily and amounts consumed might not have been 
enough to translate to observable changes in BP and other parameters. 
 
CRP is a well-established inflammatory marker and, therefore, increases in the presence of 
inflammation (Teixeira et al. 2014). It is also used as a biomarker for ED (Teixeira et al. 2014). According 
to literature tea polyphenols are able to directly inhibit inflammation, Fig 2.5 section 2.6.5 (Gonzalez 
De Mejia et al. 2013). The results for the second aim of the present study are most important and 
significant in the study of rooibos as a nutraceutical product and the safety of the current ART regimen. 
The current ART regimen showed no significant inflammatory effects. This may be why rooibos 
consumption did not result in any observed ameliorating effects. Results of the animal aspect of the 
study have indicated the possible beneficial effects of rooibos to be most effectively harnessed under 
stress conditions.  
 
The variances and lack of significant results in the investigation of the second aim are possibly due to 
an interplay of the following factors: 
1) A small sample size which was further subdivided into groups (no Rooibos no ART, Rooibos no 
ART and Rooibos on ART). 
2) Limited biochemical tests due to monetary and logistical constraints. Perhaps with the 
investigation of TAC or the use of a supplementary antioxidant tests, e.g conjugated dienes, 
significant differences might have been observed.  
3) Observational study which, for rooibos drinking, relied on accurate reporting by the 
participants. Maybe if the rooibos had been given as an intervention, in set quantities and for 
a certain period of time significant changes may have resulted. 
4) The specific FDC investigated may not, until a certain period, have deleterious effects on the 
cardiovascular system. 
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Chapter 6 – Summary and Final Conclusion 
 
6.1 Summary 
 
With the number of deaths attributable to AIDS clearly rising in the long term HIV positive population 
and the 2012 roll out of the new first line ART regimen in the form of a FDC of 
efavirenz/emtricitabine/tenofovir (Clinicians Society 2013; Statistics South Africa 2015), there is a 
clear gap in the literature which investigates the effects of this FDC in SA and possible co-therapies. 
With long term ART induced toxicities being linked to chronic inflammation (Currier et al. 2008; 
Schulenberg & Le Roux 2008; Aounallah et al. 2016) the present study proposed the use of Aspalathus 
linearis/rooibos, a plant that is indigenous to SA soil and a potent source of antioxidants that have led 
to its use as a nutraceutical product in many scientific studies (Ajuwon et al. 2015). This study thus 
aimed to elucidate the cardiovascular effects of rooibos infusion supplementation during ART, on male 
Wistar rats and the effects of rooibos tea consumption on the cardiovascular profiles of patients on 
ART. 
 
To achieve these aims the study included a laboratory and an epidemiological investigation. In the 
laboratory study we treated 100 male Wistar rats with the FDC ART (600 mg EFV, 200 mg FTC, and 300 
mg TDF) according to the weekly average weights of the rats and supplied them with a weekly 2% 
(w/v) rooibos infusion as a supplement. Treatment lasted 9 weeks and thereafter working heart 
perfusions and isometric tension studies were conducted in order to elucidate the cardiovascular and 
endothelial effects of the drug and rooibos infusion. In the epidemiological study the effects of ART 
and rooibos consumption on cardiovascular profile were investigated in 105 participants of whom 23 
were HIV negative, 14 HIV positive ART naïve and 68 HIV positive and on ART. Blood samples were 
collected by a phlebotomist, BP was measured and anthropometric data recorded. Biochemical 
analyses of serum was conducted and TBARS test done in both studies to determine lipid peroxidation 
levels.   
 
No significant differences were observed in the body weights and fluid consumption of the rats 
between the groups. In the human study the the HIV negative group was found to have a significantly 
higher BMI (28.90±9.11 (kg/m2)) compared to the HIV positive on ART (24.25±6.05 (kg/m2)) group. In 
the perfusion data IS was significantly increased in the ART treated group compared to the controls 
and the Rooibos+ART treated group had a significantly increased CF at baseline compared to the ART 
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group. In the vascular reactivity/ isometric tension studies ART was found to significantly reduce Ach 
induced relaxation compared to both the control and the Rooibos + ART treated groups. Rooibos 
treatment without ART significantly increased contraction when compared to all other groups. PVAT 
reduced contraction in all treatment groups and did not significantly affect relaxation. TC levels were 
found to decrease significantly in the rooibos treated group whilst PL and TRIG and TBARS levels were 
similar between groups. The human study showed no significant differences in lipid profiles, TBARS 
and CRP levels between the groups, however, BP in HIV negative patients was found to be significantly 
higher than in the HIV positive no ART and the HIV positive on ART. 
 
The significantly higher BMI in the HIV negative group compared to the HIV positive on ART is 
supported in literature by HIV’s documented induction of weight loss through viral replication 
(Akinboro et al. 2013). The ART regimen used clearly demonstrated the potential to induce stress over 
long term through increased infarct size and reduced Ach induced relaxation in the animal study. This 
observation is supported by literature to be due to increased ROS induced stress (Bergin et al. 2015). 
The Rooibos+ ART treated group did not show the same deleterious effects as ART did on its own. 
Rooibos as a form of supplement requires further investigation so that medical science may be able 
to fully harness the health benefits of this natural plant. BP results in the current study, although not 
consistent with some international data, data from Sub-Saharan Africa supports a decreased BP in the 
HIV positive population when compared to the HIV negative population (Palacios et al. 2006; Wilson 
et al. 2009; Feigl et al. 2016). The current first line ART showed no deleterious effects in the human 
study and further long term studies where rooibos tea is used as an intervention are required.  
 
6.2 Final Conclusion 
 
When considering the research question posed in the introductory section of the study: “What are the 
cardiovascular effects of Aspalathus linearis/ rooibos infusion supplementation during ART, on male 
Wistar rats and the effects of rooibos tea consumption on the cardiovascular profiles of patients on 
ART?” the present study has successfully met the aims and thus also answered the research question. 
This study was able to elucidate effects of the FDC of efavirenz/emtricitabine/tenofovir not only in the 
laboratory but clinically as well.  
 
Given the laboratory results it may be concluded that the current ART regimen can potentially cause 
deleterious health effects in the long term- mechanism still illusive. Rooibos may be used as a possible 
supplement but further studies are required to fully unravel the conditions in which rooibos’ 
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nutraceutical properties can be completely harnessed. Because no result is a bad result, results of the 
epidemiological study showed no detrimental effects of the FDC comprising of 1 NNRTI and 2 NRTI’s 
and thus may be the safest or otherwise least detrimental combination to use as a first line therapy at 
present. 
 
Limitations of the study 
 
 The biochemical tests conducted to determine the antioxidant capacity of participants and rats. 
This was limiting because conducting different antioxidant tests such as a test for total antioxidant 
capacity (TAC) or conjugated diene’s may have better shed a light on the ROS induced effects of 
the ART used or antioxidant effects of rooibos consumption. 
 The epidemiological study being an observational study was limited to reliance on the accurate 
reporting of rooibos consumption by the participants. 
 A relatively small sample size for an epidemiology study. 
 
 
 
 
Recommendations for future research 
 
For future studies it would be useful to use more than one biochemical test to determine antioxidant 
capacity. Having an increased sample size and giving a specific amount of rooibos tea for participants 
to drink over a set period may also prove to be most beneficial. More significant changes may be 
observed if participants are followed up on over a course of perhaps 10 years, and in the laboratory 
study, a longer treatment period for the rats.  
Further studies on rooibos in different conditions of physiological stress and health need to be 
conducted. These studies should include analyses of signaling pathways in order to fully elucidate the 
mechanisms of action of rooibos and the conditions under which its synergistic effects are most 
pronounced.  
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APPENDIX A: Odimune Dose Calculations 
 
Contents of one FDC tablet: 
Efavirenz (EFV) - 600 mg  
Emtricitabine (FTC) - 200 mg 
Tenofovir (TDF) - 300 mg 
 
Dose for an average 70 kg mature human 
Let EFV 600 mg= x 
Therefore human dose (xH) in mg/kg/day = x/70 kg  
 xH (EFV)= 600 mg/70kg= 8.6mg/ kg/ day 
 xH (FTC)= 2.9 mg/kg/day 
 xH (TDF)= 4.3 mg/kg/day 
 
Human to rat conversion 
Rat dose (xR1) = xH *6 
xR1 (EFV)= 8.6*6 = 51.6 mg/kg/day 
xR1 (FTC)=  17.4 mg/kg/day 
xR1 (TDF)= 25.8 mg/kg/day 
 
For a rat weighing 250 g: 
xR2 (EFV): 12.9 mg (xR1 * 0.250) (This is adjusted according to the weekly weights of the rats) 
xR2 (FTC): 4.35 mg 
xR2 (TDF): 6.45 mg 
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To determine weight of the actual tablet allocated per rat: 
1. Weighing the tablet 
Take human dose (x) / specific dose of rat (xR2) 
i.e for EFV: 600 mg / 12.9 mg = 46.51 = xR3 
Crush tablet with mortar and pestle until completely fine. 
Therefore amount of crushed tablet to be dissolved in 1ml water for EFV 
= weight of crushed tablet / xR3 
2. Preparing the drug and water mixture 
 
 For a 4 day preparation for an entire cage, we first determine the average weight of the rats per 
cage. 
 If average weight of cage is 352 g, thus 0.352 kg: 
 Weight of tablet after crushing = 1.6 g (1600 mg) 
 Active ingredients (AI)                = 600 +200 +300 = 1100mg 
 Actual percentage of AI              = 1100 / 1600 = 67.75% 
 Average weight of rats in cage  = 352 g (0.352 kg) 
 Dose per rat                                  = EFV: 51.6 mg * 0.352 mg = 18.163 mg 
    FTC: 17.4 mg * 0.352 mg = 6.125 mg 
   TDF: 25.8 mg * 0.352 mg = 9.082 mg 
    EFV: 600 / 18.16 = (33 * 68 %) / 100 = y 
    FTC: 200/ 6.125 = (33* 68 %) / 100 = y 
    TDF: 300/ 9.082 = (33 * 68 %) / 100 = y 
 Final dose of tablet per rat: weight of tablet (x) / y 
EFV = 1600 mg/ 22.78 = 70. 22 mg 
 Powder of tablet in 1ml water = 0.07 g 
 For a 4 day preparation with 5 rats in cage = 4 * 5= 20 ml water  
Therefore final dose = 0.070 g * 20 = 1.40 g/ 20 ml water 
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APPENDIX B: LC- MS of Rooibos 
  
LC-MS conducted by the Central Analytical Facility (CAF) of Stellenbosch 
Phenolics method 
 
A Waters Synapt G2 quadrupole time-of-flight mass spectrometer was used for LC-MS analysis.  It 
was fitted with a Waters Ultra pressure liquid chromatograph and photo diode array detection.  
Separation was achieved on a Waters HSS T3, 2.1x150 mm column with 1.7 um particles.  A gradient 
was applied using 0.1% formic acid (solvent A) and acetonitrile containing 0.1% formic acid (solvent 
B).  The gradient started at 100% solvent A for 1 minute and changed to 28 % B over 22 minutes in a 
linear way.  It then went to 40% B over 50 seconds and a wash step of 1.5 minutes at 100% B, 
followed by re-equilibration to initial conditions for 4 minutes.  The flow rate was 0.3 ml/min and the 
column was kept at 55 ºC. The injection volume was 1 µL. 
 
Data was acquired in MSE mode which consisted of a low collision energy scan (6V) from m/z 150 to 
1500 and a high collision energy scan from m/z 40 to 1500.  The high collision energy scan was done 
using a collision energy ramp of 30-60V.  The photo diode array detector was set to scan from 220-
500 nm. 
 
The mass spectrometer was optimized for best sensitivity, a cone voltage of 15 V, desolvation gas 
was nitrogen at 650 L/hr and desolvation temperature 275 ºC.  The instrument was operated with an 
electrospray ionization probe in the negative mode.  Sodium formate was used for calibration and 
leucine encephalin was infused in the background as lock mass for accurate mass determinations. 
 
Sample names: 
DP_Tyg_160914_2 D7 Fresh 
DP_Tyg_160914_3 D7 Fridge 
DP_Tyg_160914_4 D1 Fresh 
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DP_Tyg_160914_5 D7 Frozen 
DP_Tyg_160914_6 D1 Frozen 
DP_Tyg_160914_7 D1 Fridge 
 
 
D7 Fresh
Time
2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00 26.00 28.00
%
0
2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00 26.00 28.00
%
0
2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00 26.00 28.00
%
0
DP_Tyg_160914_5 1: TOF MS ES- 
BPI
5.81e416.66
609.1415.43
447.0914.11
449.11
13.54;449.11
13.38;449.11
9.51
205.071.51
165.04 7.78
255.055.26
613.14
2.57
643.17
11.32
611.16
12.71
609.15
17.22
431.10 23.66
301.03
18.68
469.13
21.27
361.17
20.44
461.11
19.29
291.13
22.43
329.14
23.76;285.04
24.27
327.22 26.25
265.15
DP_Tyg_160914_3 1: TOF MS ES- 
BPI
5.81e4
16.09
451.1215.43;447.09
13.54;449.11
13.38;449.11
9.51
205.071.27272.96 7.79255.055.24
613.14
11.32
611.16
12.70
609.15
16.67;609.15
17.23;431.10
23.69
301.04
18.69
469.13 21.27
361.16
19.73
187.10
22.44
329.14
23.78;285.04
24.27
327.22 26.26
555.28
DP_Tyg_160914_2 1: TOF MS ES- 
BPI
5.81e4
16.07;451.12
15.43
447.0914.10
449.1113.56;449.11
13.38;449.11
9.52
205.071.25
272.96 7.80
255.055.26
613.14
11.32
611.16
12.71
609.14
23.67
301.04
17.22
431.10
18.46
435.13
21.27
361.17
19.65
609.15
22.43
329.14
26.26
577.27
23.76;285.04
24.31
299.06
D1 Fridge
Time
2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00 26.00 28.00
%
0
2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00 26.00 28.00
%
0
2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00 26.00 28.00
%
0
DP_Tyg_160914_7 1: TOF MS ES- 
BPI
4.69e4
16.65
609.1515.40
447.0914.08
449.1113.55;449.11
13.38;449.11
9.50
205.071.59
223.05 7.76
255.055.24
613.15
11.32
611.16
12.69
609.15
17.20
431.10
23.76
285.04
18.68
469.13
21.27
361.17
20.40
551.21
22.43
329.14
24.29
299.05 26.25
265.15
DP_Tyg_160914_6 1: TOF MS ES- 
BPI
4.69e4
16.65;609.1415.37
447.0914.09
449.11
13.55;449.11
13.38;449.11
9.53
205.07
1.61
223.05 7.78
255.055.24
613.14
11.32
611.16
12.72
609.14
17.21
431.10
23.65
301.03
18.68
469.14
21.26
361.17
20.45
461.11
19.32
291.13
22.79
287.05
23.76;285.04
24.27
327.22
26.25
265.15
DP_Tyg_160914_4 1: TOF MS ES- 
BPI
4.69e4
15.43;447.09
15.39;447.09
14.09;449.11
13.38;449.11
9.52
205.071.51
165.04 7.79
255.055.25
613.14
11.21
611.16
12.71
609.14
16.66;609.15
17.23
431.10 23.65
301.04
18.69
469.13
21.27
361.17
20.46;461.11
22.80
287.06
23.76;285.04
24.27;327.22
26.25;265.15
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D1 Fridge
Time
2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00 26.00 28.00
%
0
2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00 26.00 28.00
%
0
DP_Tyg_160914_7 1: TOF MS ES- 
BPI
4.60e4
16.65
609.1515.40
447.0914.08
449.11
13.55;449.11
13.38;449.11
9.50
205.071.59
223.05 7.76
255.05
5.24
613.15
9.70;339.07
11.32;611.16
12.69
609.15
17.20
431.10
23.76
285.04
18.68
469.13
21.27
361.17
20.40
551.21
22.43
329.14
24.29
299.05 26.25
265.15
DP_Tyg_160914_3 1: TOF MS ES- 
BPI
4.60e4
16.09;451.12
15.43;447.09
14.10;449.11
13.38;449.11
9.51
205.071.27
272.96 7.79
255.051.63;221.03
7.08;169.015.24;613.14
8.58;357.08
11.32
611.16 12.70609.15
17.23
431.10
23.69
301.04
18.69
469.13
21.27
361.16
19.73
187.10
22.44
329.14
23.78;285.04
24.27
327.22
26.26
555.28
D7 Fresh
Time
2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00
%
0
DP_Tyg_160914_2 1: TOF MS ES- 
BPI
5.81e4
16.07;451.12
15.43
447.09
14.10
449.11
13.56
449.11
13.38;449.11
9.52
205.07
1.25
272.96
7.80
255.051.66;217.04
5.26
613.14
8.59
357.08
9.70;339.07
11.32
611.16
10.16
341.09
12.71
609.14
12.06
177.02
23.67
301.04
17.22
431.10
18.46
435.13
18.70;469.13
21.27
361.17
19.65
609.15
20.40
551.22
22.43
329.14
23.76;285.04
24.31
299.06
24.35;329.23
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D7 Fridge
Time
2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00
%
0
DP_Tyg_160914_3 1: TOF MS ES- 
BPI
4.60e4
16.09;451.12
15.43
447.09
15.39;447.09
13.54
449.11
13.38;449.11
9.51
205.07
1.27
272.96
1.51;165.04 7.79
255.05
1.63;221.03
7.08;169.015.24613.14
8.58
357.08
9.70;339.07
11.32
611.16
11.24;611.16
12.70
609.15
16.67
609.15
17.23
431.10
23.69
301.04
18.69
469.13
21.27
361.16
19.73
187.10
22.44
329.14
21.99
329.14
23.78;285.04
24.27
327.22
24.35;329.23
D1 Fresh
Time
2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00
%
0
DP_Tyg_160914_4 1: TOF MS ES- 
BPI
4.69e4
15.43;447.09
15.39;447.09
14.09
449.11
13.55;449.11
13.38;449.11
9.52
205.07
1.51
165.04
7.79
255.05
5.25
613.14
8.58
357.08
9.70;339.07
11.21
611.1610.16
341.09
12.71
609.14
16.66
609.15
17.23
431.10
23.65
301.04
18.69
469.13
21.27
361.17
20.46
461.1119.73
187.10
22.80
287.0622.01
329.14
23.76;285.04
24.27
327.22
24.35;329.23
Stellenbosch University  https://scholar.sun.ac.za
95 
 
 
 
D7 Frozen
Time
2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00
%
0
DP_Tyg_160914_5 1: TOF MS ES- 
BPI
5.13e4
16.66;609.14
15.43
447.09
14.11
449.11
13.54
449.11
13.38;449.11
9.51
205.07
1.51
165.04
7.78
255.05
1.61;221.03
5.26
613.142.57
643.17
6.40
271.05
8.58
357.08
9.68;339.07
11.32
611.16
10.17
341.09
12.71
609.15
12.08
177.02
16.09
451.12
17.22
431.10
23.66
301.03
18.68
469.13
21.27
361.17
20.44
461.11
19.29
291.13
22.43
329.14
21.99
329.14
23.76;285.04
24.27
327.22
24.36;329.23
D1 Frozen
Time
2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00
%
0
DP_Tyg_160914_6 1: TOF MS ES- 
BPI
4.65e4
16.65;609.14
15.37
447.09
14.09
449.11
13.55
449.11
13.38;449.11
9.53
205.071.61
223.05
7.78
255.05
7.38;255.055.24
613.14
8.57
357.08
9.71;339.07
11.32;611.16
11.22;611.16
10.72
595.13
12.08
177.02
17.21
431.10
23.65
301.03
18.68
469.14
21.26
361.17
20.45
461.1119.32
291.13
22.79
287.05
21.99
329.14
23.76;285.04
24.27
327.22
24.36;329.23
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Helpful hints in interpreting MS results from Masslynx data 
 
1. The ionization mode is indicated in the top right hand corner of spectra: 
 
ESMS and LCMS lab (more suitable for non-volatile compounds): 
ES+ =  Electrospray positive: Typically a M+H or M+Na ion is observed 
ES-=  Electrospray negative: Only used for molecules that can be negatively charged like phenols 
and carboxylic acids, typically a M-H or M+Cl is observed 
 
APCI = Atmospheric pressure chemical ionization: A softer technique for non-polar molecules – 
rarely used 
GCMS (more suitable for smaller and volatile compounds): 
EI = Electron impact, this is a harsher ionization technique.  A fragmentation pattern and M+ is 
sometimes observed 
D1 Fridge
Time
2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00
%
0
DP_Tyg_160914_7 1: TOF MS ES- 
BPI
4.37e4
16.65;609.15
15.40
447.09
14.08
449.11
14.07;449.11
13.38;449.11
9.50
205.07
1.59
223.05
7.76
255.05
5.24
613.15
8.57
357.08
9.70;339.07
11.32
611.16
10.14
341.09
12.69
609.15
16.05
451.13
17.20
431.10
23.76
285.04
23.64;301.03
18.68
469.13
21.27
361.17
20.40
551.2119.30291.13
22.43
329.14
21.97
329.14
24.29
299.05
24.36;329.23
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2. The retention time is given on the top left hand corner of a spectrum after the file name in 
brackets for GCMS and LCMS results. 
 
3. Only the TOF instruments  (GCT and Synapt) are capable of High resolution, samples should 
be pure and free of salts and buffers.  Most journals require that the ppm deviation from the 
theoretical mass should be less than 5 ppm or in the case of very small molecules it should 
differ by less than 2 mDa.  The iFit Confidence % gives an indication of how well the isotope 
pattern correlates to the theoretical pattern. 
 
4. Advanced MS analysis techniques (MSMS, ion mobility and high resolution LCMS and 
LCMSMS analysis) require day bookings. 
 
5. Mass spectrometry is not a universal technique, especially the atmospheric ionization 
techniques (ESI and APCI) give no representation of the purity of compounds: different 
compounds have different ionization potentials under different conditions. 
 
6. ASAP probe: This is a solids technique that uses APCI to ionize molecules from the tip of a 
melting point tube. This technique is labour intensive and time consuming and will only be 
used as last resort for insoluble and unstable molecules. The cost is the same as for LCMS 
analysis. 
 
Standard Terms and Conditions 
1. Ownership of the data and/or samples provided by the client shall remain so vested. 
2. All data and/or samples provided by the Client will be treated as confidential. 
3. The Analysis Report prepared by SU shall become the property of the Client after payment. 
4. Although the greatest care is taken by SU during analysis, SU accepts no responsibility for the loss 
of any work, samples or data provided by the Client. 
5. Data files will not be kept for longer than one week after delivery of the results to the Client. 
6. (Please advise the laboratory staff within one week after results have been received if any 
additional analysis or processing of data is required.  It remains the responsibility of our Clients to 
make proper backups of data.) 
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7. SU and all its employees shall in no event be liable for loss of profits or for incidental, special or 
consequential damages, whether direct or indirect, arising out of or in connection with the use of 
the Analysis Report. 
8. In the event of gross negligence on the side of SU, SU shall only be liable for the contract value. 
9. SU does not warrant or make any representations regarding the use, validity, accuracy, or 
reliability of the Analysis Report. 
10. SU shall be under no obligation to disclose proprietary analysis methodologies. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stellenbosch University  https://scholar.sun.ac.za
99 
 
References 
 
Ajuwon, O.R. et al., 2013. Protective effects of rooibos (aspalathus linearis) and/or red palm oil 
(elaeis guineensis) supplementation on tert -butyl hydroperoxide-induced oxidative 
hepatotoxicity in wistar rats. Evidence-based Complementary and Alternative Medicine, 2013. 
Ajuwon, O.R., Marnewick, J.L. & Davids, L.M., 2015. Rooibos ( Aspalathus linearis ) and its Major 
Flavonoids — Potential Against Oxidative Stress-Induced Conditions. , (May 2016), pp.171–218. 
Ajuwon, O.R., Oguntibeju, O.O. & Marnewick, J.L., 2014. Amelioration of lipopolysaccharide-induced 
liver injury by aqueous rooibos (Aspalathus linearis) extract via inhibition of pro-inflammatory 
cytokines and oxidative stress. BMC complementary and alternative medicine, 14(1), p.392. 
Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4201726&tool=pmcentrez&rende
rtype=abstract. 
Akinboro, A.O. et al., 2013. The impacts of first line highly active antiretroviral therapy on serum 
selenium, CD4 count and body mass index: a cross sectional and short prospective study. The 
Pan African medical journal, 15, p.97. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3810121&tool=pmcentrez&rende
rtype=abstract. 
Albanes, D. et al., 1996. Alpha-Tocopherol and beta-carotene supplements and lung cancer 
incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line 
characteristics and study compliance. Journal of the National Cancer Institute, 88(21), pp.1560–
1570. 
Alegre, F. et al., 2013. Evidence of an interplay between ER stress/UPR and mitochondria in human 
hepatic cells treated with the antiretroviral drug Efavirenz. Free Radical Biology and Medicine, 
65(2013), p.S18. Available at: 
http://www.sciencedirect.com/science/article/pii/S0891584913005522. 
Aounallah, M. et al., 2016. Current topics in HIV pathogenesis, part 2: Inflammation drives a 
Warburg-like effect on the metabolism of HIV-infected subjects. Cytokine & Growth Factor 
Reviews, (2015). Available at: http://linkinghub.elsevier.com/retrieve/pii/S1359610115300204. 
Apostolova, N. et al., 2013. ER stress in human hepatic cells treated with Efavirenz: Mitochondria 
again. Journal of Hepatology, 59(4), pp.780–789. Available at: 
Stellenbosch University  https://scholar.sun.ac.za
100 
 
http://dx.doi.org/10.1016/j.jhep.2013.06.005. 
Appay, V. & Sauce, D., 2008. Immune activation and inflammation in HIV-1 infection:causes and 
consequences. The Journal of pathology, 214(September), pp.114–125. 
Arts, E.J. & Hazuda, D.J., 2012. HIV-1 Antiretroviral Drug Therapy. Cold Spring Harbor Perspectives in 
Medicine, 2(4), pp.a007161–a007161. Available at: 
http://perspectivesinmedicine.cshlp.org/content/2/4/a007161.abstract [Accessed October 21, 
2015]. 
Ashley, N.T., Weil, Z.M. & Nelson, R.J., 2012. Inflammation: Mechanisms, Costs, and Natural 
Variation. Annual Review of Ecology, Evolution, and Systematics, 43(1), p.120913143848009. 
Ayeleso, A., Oguntibeju, O. & Brooks, N., 2013. Assessment of lipid profile, antioxidant status and 
liver histopathology in rats after rooibos.pdf. , pp.348–357. 
Baba, H. et al., 2009. Studies of anti-inflammatory effects of Rooibos tea in rats. Pediatrics 
International, 51(5), pp.700–704. 
Bahadoran, Z., Mirmiran, P. & Azizi, F., 2013. Dietary polyphenols as potential nutraceuticals in 
management of diabetes: a review. Journal of diabetes and metabolic disorders, 12(1), p.43. 
Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3751738&tool=pmcentrez&rende
rtype=abstract. 
Barnes, P.J. & Karin, M., 1997. NUCLEAR FACTOR-kB — A PIVOTAL TRANSCRIPTION FACTOR IN 
CHRONIC INFLAMMATORY DISEASES. The New England Journal of Medicine, 336(December), 
pp.1066–1071. Available at: http://www.nejm.org/doi/full/10.1056/NEJM199704103361506. 
Barreira, J. et al., 2013. Insights on the Formulation of Herbal Beverages with Medicinal Claims 
According with Their Antioxidant Properties. Molecules, 18(3), pp.2851–2863. Available at: 
http://www.mdpi.com/1420-3049/18/3/2851/. 
Bastard, J.P. et al., 2014. Increased systemic immune activation and inflammatory profile of long-
term HIV-infected ART-controlled patients is related to personal factors, but not to markers of 
HIV infection severity. Journal of Antimicrobial Chemotherapy, 70(6), pp.1816–1824. 
Beelders, T. et al., 2012. Kinetic optimisation of the reversed phase liquid chromatographic 
separation of rooibos tea (Aspalathus linearis) phenolics on conventional high performance 
liquid chromatographic instrumentation. Journal of Chromatography A, 1219, pp.128–139. 
Stellenbosch University  https://scholar.sun.ac.za
101 
 
Bell, R.M., Mocanu, M.M. & Yellon, D.M., 2011. Retrograde heart perfusion: The Langendorff 
technique of isolated heart perfusion. Journal of Molecular and Cellular Cardiology, 50(6), 
pp.940–950. Available at: http://dx.doi.org/10.1016/j.yjmcc.2011.02.018. 
Beltrán-Debón, R. et al., 2011. Continuous administration of polyphenols from aqueous rooibos 
(Aspalathus linearis) extract ameliorates dietary-induced metabolic disturbances in 
hyperlipidemic mice. Phytomedicine, 18(5), pp.414–424. 
Bergin, H. et al., 2015. Anti retroviral drugs rilpivirine and efavirenz cause cardiovascular 
dysfunction: role of endoplasmic reticulum stress. Statewide Agricultural Land Use Baseline 
2015, 1, p.273. 
Birben, E. et al., 2012. Oxidative Stress and Antioxidant Defense. WAO Journal, 5, pp.9–19. 
Bolli, R. & Marban, E., 1999. Molecular and Cellular Mechanisms of Myocardial Stunning. Physiol Rev, 
79(2), pp.609–634. Available at: http://physrev.physiology.org/content/79/2/609.long. 
Bouayed, J. & Bohn, T., 2010. Exogenous Antioxidants—Double-Edged Swords in Cellular Redox 
State: Health Beneficial Effects at Physiologic Doses versus Deleterious Effects at High Doses. 
Oxidative Medicine and Cellular Longevity, 3(4), pp.228–237. Available at: 
http://www.hindawi.com/journals/omcl/2010/267025/. 
Brooks, K. et al., 2016. Treatment failure and drug resistance in HIV-positive patients on tenofovir-
based first-line antiretroviral therapy in western Kenya. Journal of the International AIDS 
Society, 19(1), pp.1–10. Available at: 
http://www.jiasociety.org/index.php/jias/article/view/20798. 
Brown, N.K. et al., 2014. Perivascular adipose tissue in vascular function and disease: A review of 
current research and animal models. Arteriosclerosis, Thrombosis, and Vascular Biology, 34(8), 
pp.1621–1630. 
Center for Drug Evaluation and Research, 2005. Guidance for Industry: Estimating the Maximum Safe 
Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers. US 
Department of Health and Human Services, (July), pp.1–27. Available at: 
http://www.fda.gov/downloads/Drugs/Guidance/UCM078932.pdf. 
Cerrato, E. et al., 2013. Acute coronary syndrome in human immunodeficiency virus patients : 
exploiting physiopathology to inform the clinical practice. OA Evidence-Based Medicine, 1(1), 
pp.1–6. 
Challem, J.J., 1997. Re: Risk factors for lung cancer and for intervention effects in CARET, the Beta-
Stellenbosch University  https://scholar.sun.ac.za
102 
 
Carotene and Retinol Efficacy trial. Journal of the National Cancer Institute, 89(4), pp.325–326. 
Available at: http://www.simplyfit.com/pdfs/NColumn130512-Ref-9.pdf. 
Cheung, M.C. et al., 2001. Antioxidant supplements block the response of HDL to simvastatin-niacin 
therapy in patients with coronary artery disease and low HDL. Arteriosclerosis, thrombosis, and 
vascular biology, 21, pp.1320–1326. 
Cimellaro, A. et al., 2016. Role of endoplasmic reticulum stress in endothelial dysfunction. Nutrition, 
Metabolism & Cardiovascular Diseases, pp.1–9. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4777263&tool=pmcentrez&rende
rtype=abstract. 
Clinicians Society, S.H., 2013. Fixed-dose combination for adults accessing antiretroviral therapy. 
Southern African Journal of HIV Medicine, 14(1). Available at: 
http://www.sajhivmed.org.za/index.php/sajhivmed/article/view/913 [Accessed June 24, 2016]. 
Consigny, P.M., 1991. Vascular smooth muscle contraction and relaxation: pathways and chemical 
modulation. Journal of Vascular and Interventional Radiology, 2(3), pp.309–317. Available at: 
http://linkinghub.elsevier.com/retrieve/pii/S1051044391722495. 
Currier, J.S. et al., 2008. Epidemiological Evidence for Cardiovascular Disease in HIV-Infected Patients 
and Relationship to Highly Active Antiretroviral Therapy. Circulation, 118(2), pp.e29–e35. 
Available at: http://circ.ahajournals.org/cgi/doi/10.1161/CIRCULATIONAHA.107.189624. 
Dau, B. & Holodniy, M., 2008. The Relationship Between HIV Infection and Cardiovascular Disease. 
Current cardiology reviews, 4(3), pp.203–218. 
Dave, J.A. et al., 2016. Anti-Retroviral Therapy Increases the Prevalence of Dyslipidemia in South 
African HIV-Infected Patients. Plos One, 11(3), p.e0151911. Available at: 
http://dx.plos.org/10.1371/journal.pone.0151911. 
Deeks, E.D. & Perry, C.M., 2010. Efavirenz / Emtricitabine / Tenofovir Disoproxil Fumarate Single-
Tablet Regimen ( Atripla Ò ). , 70(17), pp.2315–2338. 
Dillon, D.G. et al., 2013. Association of HIV and ART with cardiometabolic traits in sub-Saharan 
Africa: A systematic review and meta-analysis. International Journal of Epidemiology, 42(6), 
pp.1754–1771. 
Dludla, P. V et al., 2014. The cardioprotective effect of an aqueous extract of fermented rooibos 
(Aspalathus linearis) on cultured cardiomyocytes derived from diabetic rats. Phytomedicine : 
international journal of phytotherapy and phytopharmacology, 21(5), pp.595–601. Available at: 
Stellenbosch University  https://scholar.sun.ac.za
103 
 
http://www.sciencedirect.com/science/article/pii/S0944711313004388 [Accessed January 20, 
2016]. 
El-Sadr, W.M. et al., 2005. Effects of HIV disease on lipid, glucose and insulin levels: results from a 
large antiretroviral-naive cohort. HIV medicine, 6(2), pp.114–121. 
Fauci, A.S., 2003. HIV SPECIAL HIV and AIDS : 20 years of science. Nature Medicine, 9(7), pp.839–843. 
Available at: http://www.nature.com/naturemedicine. 
Feigl, A.B. et al., 2016. The effect of HIV and the modifying effect of anti-retroviral therapy (ART) on 
body mass index (BMI) and blood pressure levels in rural South Africa. PLoS ONE, 11(8), pp.1–
15. 
Fisher, S.D., Miller, T.L. & Lipshultz, S.E., 2006. Impact of HIV and highly active antiretroviral therapy 
on leukocyte adhesion molecules, arterial inflammation, dyslipidemia, and atherosclerosis. 
Atherosclerosis, 185(1), pp.1–11. Available at: 
http://www.sciencedirect.com/science/article/pii/S0021915005006404 [Accessed April 6, 
2016]. 
Förstermann, U. & Sessa, W.C., 2012. Nitric oxide synthases: Regulation and function. European 
Heart Journal, 33(7), pp.829–837. 
Galán, M. et al., 2014. Mechanism of endoplasmic reticulum stress-induced vascular endothelial 
dysfunction. Biochimica et Biophysica Acta - Molecular Cell Research, 1843(6), pp.1063–1075. 
Gao, Y.-J. et al., 2009. Modulation of vascular function by perivascular adipose tissue: the role of 
endothelium and hydrogen peroxide. British Journal of Pharmacology, 151(3), pp.323–331. 
Available at: http://doi.wiley.com/10.1038/sj.bjp.0707228. 
Gilani, A.H. et al., 2006. Antispasmodic effects of Rooibos tea (Aspalathus linearis) is mediated 
predominantly through K+-channel activation. Basic and Clinical Pharmacology and Toxicology, 
99(5), pp.365–373. 
Gonzalez De Mejia, E., Puangpraphant, S. & Eckhoff, R., 2013. Tea and Inflammation. 
Gresele, P. et al., 2012. Endothelial and platelet function alterations in HIV-infected patients. 
Thrombosis research, 129(3), pp.301–8. Available at: 
http://www.sciencedirect.com/science/article/pii/S0049384811006165 [Accessed January 20, 
2016]. 
Haser, G.C. & Sumpio, B., 2016. Systemic and cell-specific mechanisms of vasculopathy induced by 
Stellenbosch University  https://scholar.sun.ac.za
104 
 
human immunodefeciency virus and highly active antiretroviral therapy. Journal of Vascular 
Surgery, pp.1–11. Available at: http://dx.doi.org/10.1016/j.jvs.2016.01.036. 
van Hinsbergh, V.W.M., 2012. Endothelium--role in regulation of coagulation and inflammation. 
Seminars in immunopathology, 34(1), pp.93–106. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3233666&tool=pmcentrez&rende
rtype=abstract [Accessed April 30, 2016]. 
Ho, E. et al., 2013. Biological markers of oxidative stress: Applications to cardiovascular research and 
practice. Redox biology, 1(1), pp.483–91. Available at: 
http://www.sciencedirect.com/science/article/pii/S221323171300058X. 
Hoesel, B. & Schmid, J.A., 2013. The complexity of NF-κB signaling in inflammation and cancer. 
Molecular cancer, 12(1), p.86. Available at: http://molecular-
cancer.biomedcentral.com/articles/10.1186/1476-4598-12-86 [Accessed January 30, 2016]. 
Huang, P.L., 2003. Endothelial nitric oxide synthase and endothelial dysfunction. Current Hypertens 
Rep, 5(6), pp.473–80. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2975487&tool=pmcentrez&rende
rtype=abstract. 
Jentzsch,  a M. et al., 1996. Improved analysis of malondialdehyde in human body fluids. Free Radical 
Biology and Medicine, 20(2), pp.251–256. Available at: <Go to ISI>://A1996TN60000010. 
Jiang, B. et al., 2006. Antiretrovirals induce direct endothelial dysfunction in vivo. J Aids, 42(4), 
pp.391–395. Available at: http://www.ncbi.nlm.nih.gov/pubmed/16810107. 
Joubert, E. & Schultz, H., 2012. Production and quality aspects of rooibos tea and related products. A 
review. Journal of Applied Botany and Food Quality, 80(2), pp.138–144. Available at: 
http://pub.jki.bund.de/index.php/JABFQ/article/view/2173 [Accessed January 20, 2016]. 
Kallings, L.O., 2008. The first postmodern pandemic: 25 Years of HIV/AIDS. Journal of Internal 
Medicine, 263(3), pp.218–243. 
Katengua-Thamahane, E. et al., 2014. The combination of red palm oil and rooibos show anti-
inflammatory effects in rats. Journal of inflammation (London, England), 11(1), p.41. Available 
at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4297406&tool=pmcentrez&rende
rtype=abstract. 
Ketonen, J. et al., 2010. Periadventitial Adipose Tissue Promotes Endothelial Dysfunction via 
Stellenbosch University  https://scholar.sun.ac.za
105 
 
Oxidative Stress in Diet-Induced Obese C57Bl/6 Mice. Circulation Journal, 74(7), pp.1479–1487. 
Available at: http://joi.jlc.jst.go.jp/JST.JSTAGE/circj/CJ-09-0661?from=CrossRef. 
Krafczyk, N. et al., 2009. Oxidation of the dihydrochalcone aspalathin leads to dimerization. Journal 
of Agricultural and Food Chemistry, 57(15), pp.6838–6843. 
Kucharská, J. et al., 2004. Regeneration of coenzyme Q9 redox state and inhibition of oxidative stress 
by Rooibos tea (Aspalathus linearis) administration in carbon tetrachloride liver damage. 
Physiological Research, 53(5), pp.515–521. 
Lagrand, W.K. et al., 1999. C-Reactive Protein as a Cardiovascular Risk Factor More Than an 
Epiphenomenon? Circulation, 100, pp.96–103. 
Lambert, C.T. et al., 2016. HIV, highly active antiretroviral therapy and the heart: A cellular to 
epidemiological review. HIV Medicine, pp.411–424. 
Ledoux, J. et al., 2006. Calcium-Activated Potassium Channels and the Regulation of Vascular Tone. 
Physiology, 21(1), p.69. Available at: 
http://physiologyonline.physiology.org/cgi/content/full/21/1/69\npapers://d8e9569c-3053-
4f4e-bfb0-c8b1b3194e73/Paper/p4929. 
Lee, M.H.-H. et al., 2014. Perivascular Adipose Tissue Inhibits Endothelial Function of Rat Aortas via 
Caveolin-1 F. Miller, ed. PLoS ONE, 9(6), p.e99947. Available at: 
http://dx.plos.org/10.1371/journal.pone.0099947 [Accessed June 18, 2016]. 
Lee, W. & Bae, J.-S., 2015. Anti-inflammatory Effects of Aspalathin and Nothofagin from Rooibos 
(Aspalathus linearis) In Vitro and In Vivo. Inflammation, 38(4), pp.1502–16. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/25655391 [Accessed November 26, 2015]. 
Li, H., Horke, S. & Förstermann, U., 2013. Oxidative stress in vascular disease and its pharmacological 
prevention. Trends in Pharmacological Sciences, 34(6), pp.313–319. 
Li, H., Horke, S. & Förstermann, U., 2014. Vascular oxidative stress, nitric oxide and atherosclerosis. 
Atherosclerosis, 237(1), pp.208–19. Available at: 
http://www.sciencedirect.com/science/article/pii/S0021915014013847 [Accessed February 18, 
2016]. 
Li, W. et al., 2004. Cocaine-induced relaxation of isolated rat aortic rings and mechanisms of action: 
Possible relation to cocaine-induced aortic dissection and hypotension. European Journal of 
Pharmacology, 496(1), pp.151–158. 
Stellenbosch University  https://scholar.sun.ac.za
106 
 
Lopez, W., 2011. HIV/AIDS: A New Era of Treatment. , 1(Fall). 
Ma, L. et al., 2010. Perivascular fat-mediated vascular dysfunction and remodeling through the 
AMPK/mTOR pathway in high-fat diet-induced obese rats. Hypertension Research, 33(5), 
pp.446–453. Available at: http://www.nature.com/doifinder/10.1038/hr.2010.11. 
Margolis, A.M. et al., 2014. A Review of the Toxicity of HIV Medications. Journal of Medical 
Toxicology, 10(1), pp.26–39. Available at: http://link.springer.com/10.1007/s13181-013-0325-
8. 
Marnewick, J.L. et al., 2011. Effects of rooibos (Aspalathus linearis) on oxidative stress and 
biochemical parameters in adults at risk for cardiovascular disease. Journal of 
ethnopharmacology, 133(1), pp.46–52. Available at: 
http://www.sciencedirect.com/science/article/pii/S0378874110006379 [Accessed February 2, 
2016]. 
Marnewick, J.L. et al., 2003. Modulation of hepatic drug metabolism enzymes and oxidative status 
by rooibos (Aspalathus linearis) tea, honeybush (Cyclopia intermedia) tea, as well as green and 
black (Camellia sinensis) teas in rats. Journal of Agricultural Food Chemistry, 51, pp.8113–8119. 
Martin, K.R., 2009. Polyphenols as dietary supplements: A double-edged sword. Nutrition and 
Dietary Supplements, (December 2009), p.1. 
McKay, D.L. & Blumberg, J.B., 2007. A review of the bioactivity of South African herbal teas: rooibos 
(Aspalathus linearis) and honeybush (Cyclopia intermedia). Phytotherapy research : PTR, 21(1), 
pp.1–16. Available at: http://www.ncbi.nlm.nih.gov/pubmed/16927447 [Accessed April 23, 
2016]. 
Meintjes, G. et al., 2014. Adult antiretroviral therapy guidelines 2014. Southern African Journal of 
HIV Medicine, 15(4), pp.121–143. Available at: 
http://www.journals.co.za/WebZ/images/ejour/m_sajhiv/m_sajhiv_v15_n4_a4.pdf?sessionid=
01-33838-
1736752385&format=F\nhttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed
12&NEWS=N&AN=2015697136. 
Meydani, M. & Hasan, S.T., 2010. Dietary polyphenols and obesity. Nutrients, 2(7), pp.737–751. 
Nduka, C. et al., 2015. Impact of antiretroviral therapy on serum lipoprotein levels and 
dyslipidemias: A systematic review and meta-analysis. International Journal of Cardiology, 
199(January), pp.307–318. Available at: http://dx.doi.org/10.1016/j.ijcard.2015.07.052. 
Stellenbosch University  https://scholar.sun.ac.za
107 
 
Neely, J.R. et al., 1967. Effect of pressure development on oxygen consumption by isolated rat heart. 
American Journal of Physiology, 212, pp.804–814. 
Nikolova, V. et al., 2007. Antioxidative effects of Rooibos tea on workers occupationally exposed to 
lead. Toxicology Letters, 172(2007), pp.S119–S120. Available at: 
http://linkinghub.elsevier.com/retrieve/pii/S0378427407004559. 
Owen, M.K. et al., 2013. Perivascular adipose tissue potentiates contraction of coronary vascular 
smooth muscle: Influence of obesity. Circulation, 128(1), pp.9–18. 
Palacios, R. et al., 2006. Impact of highly active antiretroviral therapy on blood pressure in HIV-
infected patients. A prospective study in a cohort of naive patients. HIV medicine, 7(1), pp.10–
5. Available at: http://www.ncbi.nlm.nih.gov/pubmed/16313287. 
Pantsi, W.G. et al., 2011. Rooibos (Aspalathus linearis) offers cardiac protection against 
ischaemia/reperfusion in the isolated perfused rat heart. Phytomedicine, 18(14), pp.1220–
1228. Available at: http://dx.doi.org/10.1016/j.phymed.2011.09.069. 
Pefura Yone, E. et al., 2011. First-line antiretroviral therapy and dyslipidemia in people living with 
HIV-1 in Cameroon: a cross-sectional study. AIDS Research and Therapy, 8(1), p.33. 
Persson, I.A.L., 2012. The pharmacological mechanism of angiotensin-converting enzyme inhibition 
by green tea, Rooibos and enalaprilat - A study on enzyme kinetics. Phytotherapy Research, 
26(4), pp.517–521. 
Persson, I.A.-L., Josefsson, M. & Andersson, R.G.G., 2006. Tea flavanols inhibit angiotensin-
converting enzyme activity and increase nitric oxide production in human endothelial cells. 
Journal of Pharmacy and Pharmacology, 58(8), pp.1139–1144. 
Privett, K., Kunert, M.P. & Lombard, J.H., 2004. Vascular Phenotypes: High throughput 
characterization of vascular reactivity in rats conditioned on 0.4 % and 4.0 % NaCl diet. Medical 
College of Wisconsin, (User manu. 
Rajsheker, S. et al., 2010. Crosstalk between perivascular adipose tissue and blood vessels. Current 
Opinion in Pharmacology, 10(2), pp.191–196. Available at: 
http://dx.doi.org/10.1016/j.coph.2009.11.005. 
Del Rio, D. et al., 2013. Dietary (Poly)phenolics in Human Health: Structures, Bioavailability, and 
Evidence of Protective Effects Against Chronic Diseases. Antioxidants & redox signaling, 18(14), 
pp.1818–92. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/22794138\nhttp://www.pubmedcentral.nih.gov/article
Stellenbosch University  https://scholar.sun.ac.za
108 
 
render.fcgi?artid=3619154&tool=pmcentrez&rendertype=abstract. 
Rodrigues, S.M.L. et al., 2014. Tributyltin contributes in reducing the vascular reactivity to 
phenylephrine in isolated aortic rings from female rats. Toxicology Letters, 225(3), pp.378–385. 
Available at: http://dx.doi.org/10.1016/j.toxlet.2014.01.002. 
Ross, A.C. et al., 2008. Endothelial activation markers are linked to HIV status and are independent 
of antiretroviral therapy and lipoatrophy. Journal of acquired immune deficiency syndromes 
(1999), 49(5), pp.499–506. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2778267&tool=pmcentrez&rende
rtype=abstract [Accessed April 6, 2016]. 
Scholz, E.P. et al., 2010. Cardiovascular ion channels as a molecular target of flavonoids. 
Cardiovascular Therapeutics, 28(4), pp.46–52. 
Schulenberg, E. & Le Roux, P., 2008. Antiretroviral therapy and anaesthesia. Online, 14(2), pp.31–38. 
Available at: http://www.who.int/topics/antiretroviral_therapy/en/. 
Schulenburg, E. & Le Roux, P., 2008. Antiretroviral therapy and anaesthesia. Southern African 
Journal of Anaesthesia and Analgesia, 14(2), pp.31–38. Available at: 
http://www.tandfonline.com/doi/abs/10.1080/22201173.2008.10872543. 
Sena, C.M., Pereira, A.M. & Seiça, R., 2013. Endothelial dysfunction — A major mediator of diabetic 
vascular disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1832(12), 
pp.2216–2231. 
Shikuma, C.M. et al., 2004. Changes in weight and lean body mass during highly active antiretroviral 
therapy. Clin Infect Dis, 39(8), pp.1223–1230. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/15486848\nhttp://cid.oxfordjournals.org/content/39/8
/1223.full.pdf. 
Standley, L. et al., 2001. Influence of processing stages on antimutagenic and antioxidant potentials 
of rooibos tea. Journal of Agricultural and Food Chemistry, 49(1), pp.114–117. 
Statistics South Africa, 2015. South Africa. Mid-year population estimates 2015. , (July). 
Steenkamp, V., Fernandes, A. & Van Rensburg, C.E.J., 2004. Antioxidant scavenging potential of 
South African export herbal teas. South African Journal of Botany, 70(4), p.660+. Available at: 
\\eecampbell-pc\PDF\Steenkamp_etal_2004.pdf. 
Street, R.A. & Prinsloo, G., 2013. Commercially Important Medicinal Plants of South Africa : A 
Stellenbosch University  https://scholar.sun.ac.za
109 
 
Review. , 2013. 
Takhar, S.S. & O’Laughlin, K.N., 2014. Chapter 132 – HIV Infection and AIDS. Rosen’s Emergency 
Medicine - Concepts and Clinical Practice, pp.1751–1767.e2. Available at: 
http://www.sciencedirect.com/science/article/pii/B9781455706051001329. 
Teixeira, B.C. et al., 2014. Inflammatory markers, endothelial function and cardiovascular risk. Jornal 
Vascular Brasileiro, 13(2), pp.108–115. Available at: 
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-
54492014000200108&lng=en&nrm=iso&tlng=en. 
Thompson, M.R. et al., 2011. Pattern recognition receptors and the innate immune response to viral 
infection. Viruses, 3(6), pp.920–40. Available at: http://www.mdpi.com/1999-4915/3/6/920 
[Accessed January 27, 2016]. 
Torriani, F.J. et al., 2008. Endothelial function in human immunodeficiency virus-infected 
antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG 
(AIDS Clinical Trials Group) Study 5152s. Journal of the American College of Cardiology, 52(7), 
pp.569–76. Available at: http://content.onlinejacc.org/article.aspx?articleid=1139120 
[Accessed January 19, 2016]. 
Valle, L., Hernández, R. & Ávila, J., 2013. Oxidative Stress Associated to Disease Progression and 
Toxicity during Antiretroviral Therapy in Human Immunodeficiency Virus Infection. Journal of 
Virology & Microbiology, 2013, pp.1–15. Available at: 
http://www.ibimapublishing.com/journals/JVM/2013/279685/279685.html. 
Villaño, D. et al., 2010. Unfermented and fermented rooibos teas (Aspalathus linearis) increase 
plasma total antioxidant capacity in healthy humans. Food Chemistry, 123(3), pp.679–683. 
Available at: http://www.sciencedirect.com/science/article/pii/S0308814610005923 [Accessed 
February 2, 2016]. 
Villanueva, C. & Kross, R.D., 2012. Antioxidant-induced stress. International Journal of Molecular 
Sciences, 13(2), pp.2091–2109. 
Wand, H. et al., 2007. Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after 
initiation of antiretroviral therapy in HIV infection. Aids, 21(18), pp.2445–2453. Available at: 
http://shibboleth.ovid.com/secure/?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed8&AN=20
07566978\nhttp://sfx.kcl.ac.uk/kings?sid=OVID:embase&id=pmid:&id=doi:10.1097/QAD.0b013
e3282efad32&genre=article&atitle=Metabolic+syndrome,+cardiovascular+disease+and+type+2
Stellenbosch University  https://scholar.sun.ac.za
110 
 
. 
Western Cape Government, 2015. Socio-economic Profile Overberg District Municipality Working 
Paper. 
Wilson, S.L. et al., 2009. Effects of HIV status and antiretroviral therapy on blood pressure. HIV 
medicine, 10(6), pp.388–394. 
World Health Organization, 2015. Guidelines Guideline on When To Start Antiretroviral Therapy and 
on Pre-Exposure Prophylaxis for Hiv. World Health Organization, (September), p.78. Available 
at: http://www.who.int/hiv/pub/guidelines/earlyrelease-arv/en/. 
Zanotti, I. et al., 2015. Atheroprotective effects of (poly)phenols: a focus on cell cholesterol 
metabolism. Food Funct., 6(1), pp.13–31. Available at: http://xlink.rsc.org/?DOI=C4FO00670D. 
Zimmer, H., 1998. The Isolated Perfused Heart and Its Pioneers. News in physiological sciences : an 
international journal of physiology produced jointly by the International Union of Physiological 
Sciences and the American Physiological Society, 13(August), pp.203–210. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/11390791. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stellenbosch University  https://scholar.sun.ac.za
111 
 
 
 
 
Stellenbosch University  https://scholar.sun.ac.za
